UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~April 1,~~September 30, 2022


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

(Commission File Number) 001-39317

ON SEMICONDUCTOR CORPORATION

(Exact name of registrant as specified in its charter)


Delaware						36-3840979
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

5005 E. McDowell Road

Phoenix, AZ 85008

(602) 244-6600

(Address, zip code and telephone number, including area code, of principal executive offices)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	ON	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act


Large Accelerated Filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No x

The number of shares outstanding of the issuer's class of common stock as of the close of business on ~~April 27,~~October 26, 2022:


Title of Each Class						Number of Shares
Common Stock, par value $0.01 per share						~~434,505,663~~432,423,573

Table of Contents

ON SEMICONDUCTOR CORPORATION FORM 10-Q

TABLE OF CONTENTS


Part I: Financial Information
	Item 1. Financial Statements (unaudited)	4
	Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	2429
	Item 3. Quantitative and Qualitative Disclosures About Market Risk	3139
	Item 4. Controls and Procedures	3139
Part II: Other Information
	Item 1. Legal Proceedings	3240
	Item 1A. Risk Factors	3240
	Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	3341
	Item 3. Defaults Upon Senior Securities	3341
	Item 4. Mine Safety Disclosures	3341
	Item 5. Other Information	3341
	Item 6. Exhibits	3442
	Signatures	3543

(See the glossary of selected terms immediately following this table of contents for definitions of certain abbreviated terms)

Table of Contents

ON SEMICONDUCTOR CORPORATION

FORM 10-Q

GLOSSARY OF SELECTED ABBREVIATED TERMS*


Abbreviated Term						Defined Term
0% Notes						0% Convertible Senior Notes due 2027
1.00% Notes						1.00% Convertible Senior Notes due 2020
1.625% Notes						1.625% Convertible Senior Notes due 2023

3.875% Notes						3.875% Senior Notes due 2028
ADAS						Advanced driver-assistance systems
AEC						Automotive Electronics Council
Amended Credit Agreement						Credit Agreement, dated as of April 15, 2016, as subsequently amended, by and among the Company, as borrower, the several lenders party thereto, Deutsche Bank AG, New York Branch, as administrative agent and collateral agent, and certain other parties, providing for the Revolving Credit Facility and the Term Loan “B” Facility
Amended and Restated SIP						ON Semiconductor Corporation Amended and Restated Stock Incentive Plan, as amended




ASU						Accounting Standards Update









CAMT						Corporate alternative minimum tax
Commission or SEC						Securities and Exchange Commission
ESPP						ON Semiconductor Corporation 2000 Employee Stock Purchase Plan, as amended
Exchange Act						Securities Exchange Act of 1934, as amended

FASB						Financial Accounting Standards Board
GTAT						GT Advanced Technologies Inc.



IP						Intellectual property


















IPRD						In-process research and development
IRS						United States Internal Revenue Service
OEM						Original Equipment Manufacturer
QCS						Division within ASG, primarily associated with the legacy Quantenna division
Revolving Credit Facility						A $1.97 billion revolving credit facility created pursuant to the Amended Credit Agreement
ROU						Right-of-use
RSU						Restricted stock unit




Securities Act						Securities Act of 1933, as amended



Term Loan "B" Facility						A $2.4 billion term loan "B" facility created pursuant to the Amended Credit Agreement

* Terms used, but not defined, within the body of the Form 10-Q are defined in this Glossary.

Table of Contents

PART I: FINANCIAL INFORMATION

Item 1. Financial Statements (unaudited)

ON SEMICONDUCTOR CORPORATION

CONSOLIDATED BALANCE SHEETS

(in millions, except share and per share data)

(unaudited)


		April 1, 2022		December 31, 2021			September 30, 2022		December 31, 2021
Assets	Assets					Assets
Cash and cash equivalents	Cash and cash equivalents	$	1,645.1	$	1,352.6	Cash and cash equivalents	$	2,450.2	$	1,352.6

Receivables, net	Receivables, net	910.7		809.4		Receivables, net	857.3		809.4
Inventories	Inventories	1,496.0		1,379.5		Inventories	1,575.4		1,379.5
Assets held-for-sale						Assets held-for-sale	135.0		—
Other current assets	Other current assets	315.6		240.1		Other current assets	291.5		240.1

Total current assets	Total current assets	4,367.4		3,781.6		Total current assets	5,309.4		3,781.6

Property, plant and equipment, net	Property, plant and equipment, net	2,559.4		2,524.3		Property, plant and equipment, net	2,762.1		2,524.3
Goodwill	Goodwill	1,936.7		1,937.5		Goodwill	1,600.4		1,937.5
Intangible assets, net	Intangible assets, net	474.5		495.7		Intangible assets, net	373.8		495.7
Deferred tax assets	Deferred tax assets	349.3		366.3		Deferred tax assets	409.9		366.3
Other assets	Other assets	525.1		520.6		Other assets	645.1		520.6
Total assets	Total assets	$	10,212.4	$	9,626.0	Total assets	$	11,100.7	$	9,626.0
Liabilities, Non-Controlling Interest and Stockholders’ Equity	Liabilities, Non-Controlling Interest and Stockholders’ Equity					Liabilities, Non-Controlling Interest and Stockholders’ Equity
Accounts payable	Accounts payable	$	725.3	$	635.1	Accounts payable	$	791.7	$	635.1
Accrued expenses and other current liabilities	Accrued expenses and other current liabilities	670.4		747.6		Accrued expenses and other current liabilities	766.7		747.6
Liabilities held-for-sale						Liabilities held-for-sale	37.3		—
Current portion of long-term debt	Current portion of long-term debt	170.4		160.7		Current portion of long-term debt	165.3		160.7
Total current liabilities	Total current liabilities	1,566.1		1,543.4		Total current liabilities	1,761.0		1,543.4
Long-term debt	Long-term debt	3,035.4		2,913.9		Long-term debt	3,046.5		2,913.9
Deferred tax liabilities	Deferred tax liabilities	40.9		43.2		Deferred tax liabilities	30.5		43.2
Other long-term liabilities	Other long-term liabilities	552.0		521.1		Other long-term liabilities	586.1		521.1
Total liabilities	Total liabilities	5,194.4		5,021.6		Total liabilities	5,424.1		5,021.6
Commitments and contingencies (Note 10)		0		0
Commitments and contingencies (Note 11)						Commitments and contingencies (Note 11)
ON Semiconductor Corporation stockholders’ equity:	ON Semiconductor Corporation stockholders’ equity:					ON Semiconductor Corporation stockholders’ equity:
Common stock ($0.01 par value, 1,250,000,000 shares authorized, 606,021,655 and 603,044,079 issued, 434,494,753 and 432,472,818 outstanding, respectively)		6.1		6.0
Common stock ($0.01 par value, 1,250,000,000 shares authorized, 606,766,278 and 603,044,079 issued, 432,406,805 and 432,472,818 outstanding, respectively)						Common stock ($0.01 par value, 1,250,000,000 shares authorized, 606,766,278 and 603,044,079 issued, 432,406,805 and 432,472,818 outstanding, respectively)	6.1		6.0
Additional paid-in capital	Additional paid-in capital	4,533.3		4,633.3		Additional paid-in capital	4,598.8		4,633.3
Accumulated other comprehensive loss	Accumulated other comprehensive loss	(26.4)		(40.6)		Accumulated other comprehensive loss	(23.4)		(40.6)
Accumulated earnings	Accumulated earnings	2,992.4		2,435.1		Accumulated earnings	3,760.1		2,435.1
Less: Treasury stock, at cost: 171,526,902 and 170,571,261 shares, respectively		(2,507.2)		(2,448.4)
Less: Treasury stock, at cost: 174,359,473 and 170,571,261 shares, respectively						Less: Treasury stock, at cost: 174,359,473 and 170,571,261 shares, respectively	(2,685.6)		(2,448.4)
Total ON Semiconductor Corporation stockholders’ equity	Total ON Semiconductor Corporation stockholders’ equity	4,998.2		4,585.4		Total ON Semiconductor Corporation stockholders’ equity	5,656.0		4,585.4
Non-controlling interest	Non-controlling interest	19.8		19.0		Non-controlling interest	20.6		19.0
Total stockholders' equity	Total stockholders' equity	5,018.0		4,604.4		Total stockholders' equity	5,676.6		4,604.4
Total liabilities and stockholders' equity	Total liabilities and stockholders' equity	$	10,212.4	$	9,626.0	Total liabilities and stockholders' equity	$	11,100.7	$	9,626.0

See accompanying notes to consolidated financial statements

Table of Contents

ON SEMICONDUCTOR CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

(in millions, except per share data)

(unaudited)


		Quarters Ended				Quarters Ended				Nine Months Ended
		April 1, 2022		April 2, 2021				September 30, 2022		October 1, 2021		September 30, 2022		October 1, 2021
Revenue	Revenue	$	1,945.0	$	1,481.7		Revenue	$	2,192.6	$	1,742.1	$	6,222.6	$	4,893.7
Cost of revenue (exclusive of amortization shown below)	Cost of revenue (exclusive of amortization shown below)	983.7		960.5			Cost of revenue (exclusive of amortization shown below)	1,134.3		1,021.3		3,165.9		3,011.6
Gross profit	Gross profit	961.3		521.2			Gross profit	1,058.3		720.8		3,056.7		1,882.1
Operating expenses:	Operating expenses:						Operating expenses:
Research and development	Research and development	156.8		173.6			Research and development	145.4		154.5		463.8		494.4
Selling and marketing	Selling and marketing	71.1		78.9			Selling and marketing	69.5		68.4		213.7		223.4
General and administrative	General and administrative	77.9		72.4			General and administrative	84.9		75.7		246.0		221.3

Amortization of acquisition-related intangible assets	Amortization of acquisition-related intangible assets	21.3		25.0			Amortization of acquisition-related intangible assets	21.9		24.7		65.1		74.5
Restructuring, asset impairments and other charges, net		(13.0)		42.5
Intangible asset impairment		—		2.9
Restructuring, asset impairments and other, net							Restructuring, asset impairments and other, net	40.3		(1.7)		25.6		58.3
Goodwill and intangible asset impairment							Goodwill and intangible asset impairment	271.8		—		386.8		2.9
Total operating expenses	Total operating expenses	314.1		395.3			Total operating expenses	633.8		321.6		1,401.0		1,074.8
Operating income	Operating income	647.2		125.9			Operating income	424.5		399.2		1,655.7		807.3
Other income (expense), net:	Other income (expense), net:						Other income (expense), net:
Interest expense	Interest expense	(21.6)		(33.4)			Interest expense	(23.7)		(31.9)		(67.4)		(98.4)
Interest income	Interest income	0.4		0.4			Interest income	4.9		0.5		6.4		1.1
Loss on debt refinancing and prepayment							Loss on debt refinancing and prepayment	—		—		(7.3)		(26.2)

Gain on divestiture of business							Gain on divestiture of business	0.2		10.2		2.1		10.2

Other income (expense)	Other income (expense)	2.1		4.5			Other income (expense)	0.9		(5.8)		9.4		(2.4)
Other income (expense), net	Other income (expense), net	(19.1)		(28.5)			Other income (expense), net	(17.7)		(27.0)		(56.8)		(115.7)
Income before income taxes	Income before income taxes	628.1		97.4			Income before income taxes	406.8		372.2		1,598.9		691.6
Income tax provision	Income tax provision	(97.1)		(7.1)			Income tax provision	(94.9)		(61.8)		(299.4)		(106.8)
Net income	Net income	531.0		90.3			Net income	311.9		310.4		1,299.5		584.8
Less: Net income attributable to non-controlling interest	Less: Net income attributable to non-controlling interest	(0.8)		(0.4)			Less: Net income attributable to non-controlling interest	—		(0.7)		(1.6)		(1.1)
Net income attributable to ON Semiconductor Corporation	Net income attributable to ON Semiconductor Corporation	$	530.2	$	89.9		Net income attributable to ON Semiconductor Corporation	$	311.9	$	309.7	$	1,297.9	$	583.7

Net income for diluted earnings per share of common stock (Note 8)		530.7		89.9
Net income for diluted earnings per share of common stock (Note 9)							Net income for diluted earnings per share of common stock (Note 9)	312.4		309.7		$	1,299.4	$	583.7
Net income per share of common stock:	Net income per share of common stock:						Net income per share of common stock:
Basic	Basic	$	1.22	$	0.22		Basic	$	0.72	$	0.72	$	2.99	$	1.38
Diluted	Diluted	$	1.18	$	0.20		Diluted	$	0.70	$	0.70	$	2.90	$	1.32
Weighted-average shares of common stock outstanding:	Weighted-average shares of common stock outstanding:						Weighted-average shares of common stock outstanding:
Basic	Basic	433.3		413.4			Basic	432.9		430.6		433.5		423.8
Diluted	Diluted	448.9		445.4			Diluted	448.7		440.7		448.3		443.1

Comprehensive income, net of tax:	Comprehensive income, net of tax:						Comprehensive income, net of tax:
Net income	Net income	$	531.0	$	90.3		Net income	$	311.9	$	310.4	$	1,299.5	$	584.8
Foreign currency translation adjustments	Foreign currency translation adjustments	(2.4)		(2.3)			Foreign currency translation adjustments	(1.8)		(0.3)		(8.4)		(2.8)
Effects of cash flow hedges and other adjustments	Effects of cash flow hedges and other adjustments	16.6		4.0			Effects of cash flow hedges and other adjustments	7.7		3.9		25.6		11.8

Other comprehensive income, net of tax	Other comprehensive income, net of tax	14.2		1.7			Other comprehensive income, net of tax	5.9		3.6		17.2		9.0
Comprehensive income	Comprehensive income	545.2		92.0			Comprehensive income	317.8		314.0		1,316.7		593.8
Comprehensive income attributable to non-controlling interest	Comprehensive income attributable to non-controlling interest	(0.8)		(0.4)			Comprehensive income attributable to non-controlling interest	—		(0.7)		(1.6)		(1.1)
Comprehensive income attributable to ON Semiconductor Corporation	Comprehensive income attributable to ON Semiconductor Corporation	$	544.4	$	91.6		Comprehensive income attributable to ON Semiconductor Corporation	$	317.8	$	313.3	$	1,315.1	$	592.7

See accompanying notes to consolidated financial statements

Table of Contents

ON SEMICONDUCTOR CORPORATION

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(in millions, except share data)

(unaudited)


		Common Stock					Additional Paid-in Capital			Accumulated Other Comprehensive Loss						Treasury Stock					Non-Controlling Interest							Common Stock			Additional Paid-in Capital		Accumulated Other Comprehensive Loss				Treasury Stock			Non-Controlling Interest
		Number of shares		At Par Value									Accumulated Earnings			Number of shares		At Cost						Total Equity				Number of shares	At Par Value						Accumulated Earnings		Number of shares	At Cost				Total Equity

Balance at July 1, 2022																											Balance at July 1, 2022	606,427,684	$	6.1	$	4,565.9	$	(29.3)	$	3,448.2	(173,104,824)	$	(2,601.4)	$	20.6	$	5,410.1

Shares issued pursuant to the ESPP																											Shares issued pursuant to the ESPP	149,300	—		6.0		—		—		—	—		—		6.0
RSUs and stock grant awards issued																											RSUs and stock grant awards issued	189,202	—		—		—		—		—	—		—		—

Partial settlement - 1.625% Notes																											Partial settlement - 1.625% Notes	92	—		—		—		—		—	—		—		—

Partial settlement of bond hedges - 1.625% Notes																											Partial settlement of bond hedges - 1.625% Notes	—	—		—		—		—		(90)	—		—		—

Payment of tax withholding for RSUs																											Payment of tax withholding for RSUs	—	—		—		—		—		(58,559)	(4.1)		—		(4.1)
Share-based compensation																											Share-based compensation	—	—		26.9		—		—		—	—		—		26.9
Repurchase of common stock																											Repurchase of common stock	—	—		—		—		—		(1,196,000)	(80.1)		—		(80.1)

Comprehensive income																											Comprehensive income	—	—		—		5.9		311.9		—	—		—		317.8
Balance at September 30, 2022																											Balance at September 30, 2022	606,766,278	$	6.1	$	4,598.8	$	(23.4)	$	3,760.1	(174,359,473)	$	(2,685.6)	$	20.6	$	5,676.6
			Number of shares			At Par Value			Additional Paid-in Capital			Accumulated Other Comprehensive Loss			Accumulated Earnings		Number of shares			At Cost			Non-Controlling Interest			Total Equity
Balance at December 31, 2021	Balance at December 31, 2021	Balance at December 31, 2021																										603,044,079	$	6.0	$	4,633.3	$	(40.6)	$	2,435.1	(170,571,261)	$	(2,448.4)	$	19.0	$	4,604.4
Impact of the adoption of ASU 2020-06	Impact of the adoption of ASU 2020-06	—		—			27.1									—		—			(102.0)						Impact of the adoption of ASU 2020-06	—	—		(129.1)		—		27.1		—	—		—		(102.0)

Shares issued pursuant to the ESPP	Shares issued pursuant to the ESPP	126,388		—			6.7			—			—			—		—			—			6.7			Shares issued pursuant to the ESPP	403,518	—		18.2		—		—		—	—		—		18.2
RSUs and stock grant awards issued	RSUs and stock grant awards issued	2,851,188		0.1			(0.1)			—			—			—		—			—			—			RSUs and stock grant awards issued	3,318,351	0.1		(0.1)		—		—		—	—		—		—

Partial settlement - 1.625% Notes																											Partial settlement - 1.625% Notes	330	—		—		—		—		—	—		—		—

Partial settlement of bond hedges - 1.625% Notes																											Partial settlement of bond hedges - 1.625% Notes	—	—		—		—		—		(322)	—		—		—

Payment of tax withholding for RSUs	Payment of tax withholding for RSUs	—		—			—			—			—			(955,641)		(58.8)			—			(58.8)			Payment of tax withholding for RSUs	—	—		—		—		—		(1,091,890)	(67.4)		—		(67.4)
Share-based compensation	Share-based compensation	—		—			22.5			—			—			—		—			—			22.5			Share-based compensation	—	—		76.5		—		—		—	—		—		76.5

Repurchase of common stock																											Repurchase of common stock	—	—		—		—		—		(2,696,000)	(169.8)		—		(169.8)

Comprehensive income	Comprehensive income	—		—			—			14.2			530.2			—		—			0.8			545.2			Comprehensive income	—	—		—		17.2		1,297.9		—	—		1.6		1,316.7
Balance at April 1, 2022		606,021,655		$	6.1		$	4,533.3		$	(26.4)		$	2,992.4		(171,526,902)		$	(2,507.2)		$	19.8		$	5,018.0

Balance at September 30, 2022																											Balance at September 30, 2022	606,766,278	$	6.1	$	4,598.8	$	(23.4)	$	3,760.1	(174,359,473)	$	(2,685.6)	$	20.6	$	5,676.6

Balance at December 31, 2020 570,766,439 $ 5.7 $ 4,133.1 $ (57.6) $ 1,425.5 (158,923,810) $ (1,968.2) $ 19.6 $ 3,558.1
Shares issued pursuant to the ESPP 204,415 — 5.7 — — — — — 5.7
RSUs and stock grant awards issued 2,269,328 — — — — — — — —
Shares issued upon exercise of warrants for 1.00% Notes 6,313,262 0.1 (0.1) — — — — — —
Payment of tax withholding for RSUs — — — — — (733,223) (28.5) — (28.5)
Share-based compensation — — 22.3 — — — — — 22.3
Comprehensive income — — — 1.7 89.9 — — 0.4 92.0
Balance at April 2, 2021 579,553,444 $ 5.8 $ 4,161.0 $ (55.9) $ 1,515.4 (159,657,033) $ (1,996.7) $ 20.0 $ 3,649.6


Balance at July 2, 2021	599,397,171	$	6.0	$	4,470.3	$	(52.2)	$	1,699.5	(168,864,960)	$	(2,339.2)	$	20.0	$	3,804.4



Shares issued pursuant to the ESPP	171,146	—		5.5		—		—		—	—		—		5.5
RSUs and stock grant awards issued	170,159	—		—		—		—		—	—		—		—







Payment of tax withholding for RSUs	—	—		—		—		—		(49,512)	(2.2)		—		(2.2)
Share-based compensation	—	—		22.7		—		—		—	—		—		22.7



Comprehensive income	—	—		—		3.6		309.7		—	—		0.7		314.0
Balance at October 1, 2021	599,738,476	$	6.0	$	4,498.5	$	(48.6)	$	2,009.2	(168,914,472)	$	(2,341.4)	$	20.7	$	4,144.4

Balance at December 31, 2020	570,766,439	$	5.7	$	4,133.1	$	(57.6)	$	1,425.5	(158,923,810)	$	(1,968.2)	$	19.6	$	3,558.1


Stock option exercises	4,000	—		—		—		—		—	—		—		—
Shares issued pursuant to the ESPP	570,732	—		17.6		—		—		—	—		—		17.6
RSUs and stock grant awards issued	2,782,381	—		—		—		—		—	—		—		—
Shares issued for warrants exercise - 1.00% Notes	13,424,951	0.1		(0.1)		—		—		—	—		—		—
Partial settlement - 1.625% Notes	5,425,239	0.1		(141.7)		—		—		—	—		—		(141.6)
Partial settlement of warrants - 1.625% Notes	6,764,734	0.1		(0.1)		—		—		—	—		—		—
Partial settlement of bond hedges - 1.625% Notes	—	—		339.0		—		—		(9,120,930)	(339.0)				—
Equity component - 0% Notes	—	—		136.6		—		—		—	—		—		136.6
Warrants and bond hedges, net - 0% Notes	—	—		(66.5)		—		—		—	—		—		(66.5)
Tax impact of convertible notes, warrants and bond hedges, net	—	—		6.5		—		—		—	—		—		6.5
Payment of tax withholding for RSUs	—	—		—		—		—		(869,732)	(34.2)		—		(34.2)
Share-based compensation	—	—		74.1		—		—		—	—		—		74.1



Comprehensive income	—	—		—		9.0		583.7		—	—		1.1		593.8
Balance at October 1, 2021	599,738,476	$	6.0	$	4,498.5	$	(48.6)	$	2,009.2	(168,914,472)	$	(2,341.4)	$	20.7	$	4,144.4

See accompanying notes to consolidated financial statements

Table of Contents

ON SEMICONDUCTOR CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)

(unaudited)


		Quarters Ended					Nine Months Ended
		April 1, 2022		April 2, 2021			September 30, 2022		October 1, 2021
Cash flows from operating activities:	Cash flows from operating activities:					Cash flows from operating activities:
Net income	Net income	$	531.0	$	90.3	Net income	$	1,299.5	$	584.8
Adjustments to reconcile net income to net cash provided by operating activities:	Adjustments to reconcile net income to net cash provided by operating activities:					Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	Depreciation and amortization	140.6		153.4		Depreciation and amortization	418.6		456.4
(Gain) loss on sale or disposal of fixed assets	(Gain) loss on sale or disposal of fixed assets	(16.6)		0.3		(Gain) loss on sale or disposal of fixed assets	(33.1)		2.3

Gain on divestiture of business						Gain on divestiture of business	(2.1)		(10.2)
Loss on debt refinancing and prepayment						Loss on debt refinancing and prepayment	7.3		26.2

Amortization of debt discount and issuance costs	Amortization of debt discount and issuance costs	3.2		2.4		Amortization of debt discount and issuance costs	8.6		8.0

Share-based compensation	Share-based compensation	22.5		22.3		Share-based compensation	76.5		74.1
Non-cash interest on convertible notes	Non-cash interest on convertible notes	—		4.6		Non-cash interest on convertible notes	—		17.6
Non-cash asset impairment charges	Non-cash asset impairment charges	6.7		6.1		Non-cash asset impairment charges	18.6		10.8
Goodwill and intangible asset impairment charges						Goodwill and intangible asset impairment charges	386.8		—
Change in deferred tax balances						Change in deferred tax balances	(64.6)		39.5

Change in deferred tax balances		38.3		(23.2)
Other	Other	0.5		(2.0)		Other	0.6		0.2
Changes in assets and liabilities (exclusive of divestiture):
Changes in assets and liabilities (exclusive of divestitures):						Changes in assets and liabilities (exclusive of divestitures):
Receivables	Receivables	(107.2)		(9.9)		Receivables	(67.2)		(38.1)
Inventories	Inventories	(116.7)		(42.0)		Inventories	(196.9)		(71.5)
Other assets	Other assets	(0.8)		9.9		Other assets	(48.6)		(32.0)
Accounts payable	Accounts payable	35.7		8.9		Accounts payable	68.8		25.6
Accrued expenses and other current liabilities	Accrued expenses and other current liabilities	(83.2)		12.8		Accrued expenses and other current liabilities	4.8		55.6
Other long-term liabilities	Other long-term liabilities	24.6		(15.4)		Other long-term liabilities	24.2		6.1
Net cash provided by operating activities	Net cash provided by operating activities	$	478.6	$	218.5	Net cash provided by operating activities	$	1,901.8	$	1,155.4
Cash flows from investing activities:	Cash flows from investing activities:					Cash flows from investing activities:
Purchase of property, plant and equipment	Purchase of property, plant and equipment	$	(173.8)	$	(77.0)	Purchase of property, plant and equipment	$	(663.0)	$	(275.0)
Proceeds from sale of property, plant and equipment	Proceeds from sale of property, plant and equipment	36.7		0.2		Proceeds from sale of property, plant and equipment	59.0		6.6
Deposits utilized (made) for purchase of property, plant and equipment		1.6		(0.4)
Divestiture of business, net of cash transferred and deposits received		12.9		—
Payments related to prior acquisition		(2.4)		—
Deposits made for purchase of property, plant and equipment						Deposits made for purchase of property, plant and equipment	(53.7)		(21.5)
Divestiture of business, net of cash transferred						Divestiture of business, net of cash transferred	90.5		3.4

Purchase of available-for-sale securities	Purchase of available-for-sale securities	(7.8)		—		Purchase of available-for-sale securities	(18.0)		(43.8)
Proceeds from sale or maturity of available-for-sale securities	Proceeds from sale or maturity of available-for-sale securities	3.4		—		Proceeds from sale or maturity of available-for-sale securities	24.0		2.8

Payments related to prior acquisition						Payments related to prior acquisition	(2.4)		—

Net cash used in investing activities	Net cash used in investing activities	$	(129.4)	$	(77.2)	Net cash used in investing activities	$	(563.6)	$	(327.5)
Cash flows from financing activities:	Cash flows from financing activities:					Cash flows from financing activities:
Proceeds for the issuance of common stock under the ESPP	Proceeds for the issuance of common stock under the ESPP	$	7.8	$	6.6	Proceeds for the issuance of common stock under the ESPP	$	18.2	$	18.5

Payment of tax withholding for RSUs	Payment of tax withholding for RSUs	(58.8)		(28.5)		Payment of tax withholding for RSUs	(67.4)		(34.2)

Repurchase of common stock						Repurchase of common stock	(166.9)		—
Issuance and borrowings under debt agreements						Issuance and borrowings under debt agreements	500.0		787.3
Reimbursement of debt issuance costs						Reimbursement of debt issuance costs	—		2.7
Payment of debt issuance and other financing costs						Payment of debt issuance and other financing costs	—		(3.8)
Repayment of borrowings under debt agreements	Repayment of borrowings under debt agreements	(4.1)		(154.1)		Repayment of borrowings under debt agreements	(509.5)		(1,218.8)

Payment for purchase of bond hedges						Payment for purchase of bond hedges	—		(160.3)
Proceeds from issuance of warrants						Proceeds from issuance of warrants	—		93.8
Payments related to prior acquisition	Payments related to prior acquisition	—		(2.1)		Payments related to prior acquisition	—		(3.0)

Financing lease payment						Financing lease payment	(12.5)		—

Dividend to non-controlling shareholder	Dividend to non-controlling shareholder	(2.2)		—		Dividend to non-controlling shareholder	(2.2)		—
Net cash used in financing activities	Net cash used in financing activities	$	(57.3)	$	(178.1)	Net cash used in financing activities	$	(240.3)	$	(517.8)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	Effect of exchange rate changes on cash, cash equivalents and restricted cash	(0.7)		(0.8)		Effect of exchange rate changes on cash, cash equivalents and restricted cash	(3.2)		(1.0)
Net increase (decrease) in cash, cash equivalents and restricted cash		291.2		(37.6)
Cash, cash equivalents and restricted cash, beginning of period (Note 6)		1,377.7		1,081.5
Cash, cash equivalents and restricted cash, end of period (Note 6)		$	1,668.9	$	1,043.9
Net increase in cash, cash equivalents and restricted cash						Net increase in cash, cash equivalents and restricted cash	1,094.7		309.1
Cash, cash equivalents and restricted cash, beginning of period (Note 7)						Cash, cash equivalents and restricted cash, beginning of period (Note 7)	1,377.7		1,081.5
Cash, cash equivalents and restricted cash, end of period (Note 7)						Cash, cash equivalents and restricted cash, end of period (Note 7)	$	2,472.4	$	1,390.6

See accompanying notes to consolidated financial statements

Table of Contents

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Note 1: Background and Basis of Presentation

ON Semiconductor Corporation ~~together~~(“onsemi,” “we,” “us,” “our,” or the “Company”) with its wholly and majority-owned subsidiaries ~~which operate~~operates under the onsemiTM brand ("onsemi," "we," "us," "our" or the "Company"), uses a thirteen-week fiscal quarter accounting period for the first three fiscal quarters of each year, with the first quarter of 2022 having ended on April 1, 2022 and each fiscal year ending on December 31. brand.

The ~~quarters ended April 1, 2022 and April 2, 2021 contained 91 and 92 days, respectively. As of April 1, 2022, the~~ Company ~~was~~is organized into the following 3three operating and reportable segments: ~~the~~

•The Power Solutions Group ("PSG")~~, the~~;

•The Advanced Solutions Group ("ASG"); and ~~the~~

•The Intelligent Sensing Group ("ISG").

The Company's fiscal calendar year begins on January 1 and ends on December 31. The fiscal quarters contain a thirteen-week accounting period. Minor day adjustments are required in the first and fourth quarters to account for the Company's fiscal calendar year's starting and ending dates. The quarters ended September 30, 2022 and October 1, 2021 contained 91 days each. The nine months ended September 30, 2022 and October 1, 2021 contained 273 and 274 days, respectively.

The accompanying unaudited financial statements as of and for the quarter and nine months ended ~~April 1,~~September 30, 2022 have been prepared ~~in accordance with~~following generally accepted accounting principles in the United States of America ("GAAP"). Accordingly, the unaudited financial statements do not include all of the information and footnotes required by GAAP for audited financial statements. The balance sheet as of December 31, 2021 was derived from the Company's audited financial statements but does not include all disclosures required by GAAP for audited financial statements. In the opinion of the Company's management, the interim information ~~includes~~contains all adjustments, which include normal recurring adjustments necessary for a fair statement of the results for the interim periods. The footnote disclosures related to the interim financial information ~~included~~contained herein are also unaudited. Such financial information should be read in conjunction with the consolidated financial statements and related notes thereto for the year ended December 31, 2021, included in the Company's Annual Report on Form 10-K for the year ended December 31, 2021, which was filed with the SEC on February 14, 2022 (the "2021 Form 10-K").

Use of Estimates

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amount of revenue and expenses during the reporting period. Management evaluates these estimates and judgments on an ongoing basis and bases its estimates on experience, current and expected future conditions, third-party evaluations, and various other assumptions that management believes are reasonable under the circumstances. Significant estimates have been used by management in conjunction with the following: (i) future payouts for customer incentives and amounts subject to allowances and returns; (ii) valuation and obsolescence relating to inventories; ~~and~~ (iii) measurement of valuation allowances against deferred tax assets and evaluations of uncertain tax ~~positions.~~positions and (iv) testing for impairment of long-lived assets and goodwill. Additionally, during periods where it becomes applicable, significant estimates will be used by management in determining the future cash flows used to assess and test for impairment of long-lived assets and goodwill and in assumptions used in connection with business combinations. Actual results may differ from the estimates and assumptions used in the consolidated financial statements.

Table of Contents

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Note 2: Revenue and Segment Information

The Company is organized into 3three operating and reportable segments consisting of PSG, ASG and ISG. These segments represent the ~~Company’s~~Company's view of the business, and its gross profit is used to evaluate the performance of the ~~Company’s~~Company's segments, the progress of major initiatives and the allocation of resources. Gross profit is exclusive of the amortization of acquisition-related intangible assets.

During the quarter ended April 1, 2022, the Company received capacity payments and deposits of $5.5 million, which was recorded as a contract liability, of which an immaterial amount was recognized as revenue for satisfying the associated performance obligations. The remaining balances amounting to $27.6 million and $28.9 million were recorded as current liabilities and other long-term liabilities, respectively. Contract assets were immaterial as of April 1, 2022. There were no corresponding amounts for the quarter ended April 2, 2021.

A significant portion of the Company’s orders are firm commitments that are non-cancellable, including certain orders or contracts with a duration of less than one year. Certain of the Company's customer contracts are multi-year agreements that include firmly committed amounts ("Long-term Supply Agreements" or "LTSA's") for which the remaining performance obligations as of ~~April 1,~~September 30, 2022 were approximately ~~$8.6~~$14.1 billion (excluding the remaining performance obligations for contracts having a duration of one year or less). The Company expects to recognize approximately ~~30%~~31% of this amount as revenue during the next twelve months upon shipment of products under these contracts. Total sales estimates are based on negotiated contract prices and demand quantities, and could be influenced by manufacturing ~~and~~issues, supply chain constraints, and modifications to customer agreements, among other things. Accordingly, the amount represented by remaining performance obligations may not be indicative of the actual revenue recognized for future periods.

A portion of our LTSA’s include non-cancellable capacity payments which secure production availability for our customers' orders or represent deposits, which prepay a portion of a given customer’s product obligation. During the quarter and nine months ended September 30, 2022, the Company recorded capacity payments of $67.8 million and $104.1 million, respectively, which were recorded within contract liabilities. As of September 30, 2022, $22.3 million of the capacity payments were recorded in accounts receivable. Capacity payments totaled $143.8 million as of September 30, 2022, of which $40.3 million and $103.5 million were recorded as current liabilities and other long-term liabilities, respectively. Contract assets were $13.1 million as of September 30, 2022. During the quarter and nine months ended September 30, 2022, $4.7 million and $13.8 million, respectively, was recognized as revenue for satisfying the associated performance obligations.

Revenue and gross profit for the Company’s operating and reportable segments are as follows (in millions):


		PSG		ASG		ISG		Total			PSG		ASG		ISG		Total
For the quarter ended April 1, 2022:
For the quarter ended September 30, 2022:										For the quarter ended September 30, 2022:
Revenue from external customers	Revenue from external customers	$	986.7	$	689.3	$	269.0	$	1,945.0	Revenue from external customers	$	1,116.1	$	734.3	$	342.2	$	2,192.6
Gross profit	Gross profit	$	474.7	$	366.7	$	119.9	$	961.3	Gross profit	$	508.5	$	381.7	$	168.1	$	1,058.3
For the quarter ended April 2, 2021:
For the quarter ended October 1, 2021:										For the quarter ended October 1, 2021:
Revenue from external customers	Revenue from external customers	$	747.0	$	531.5	$	203.2	$	1,481.7	Revenue from external customers	$	892.1	$	613.5	$	236.5	$	1,742.1
Gross profit	Gross profit	$	246.5	$	206.8	$	67.9	$	521.2	Gross profit	$	346.0	$	280.1	$	94.7	$	720.8

For the nine months ended September 30, 2022:										For the nine months ended September 30, 2022:
Revenue from external customers										Revenue from external customers	$	3,159.8	$	2,140.3	$	922.5	$	6,222.6
Gross profit										Gross profit	$	1,494.4	$	1,128.7	$	433.6	$	3,056.7
For the nine months ended October 1, 2021:										For the nine months ended October 1, 2021:
Revenue from external customers										Revenue from external customers	$	2,485.7	$	1,752.6	$	655.4	$	4,893.7
Gross profit										Gross profit	$	906.8	$	739.2	$	236.1	$	1,882.1

The Company had one customer, a distributor, whose revenue accounted for approximately ~~12.4%~~12% and ~~10.6%~~14% of the Company's total revenue for the quarters ended ~~April 1,~~September 30, 2022 and ~~April 2,~~October 1, 2021, ~~respectively.~~respectively, and 12% and 13% of the Company's total revenue for the nine months ended September 30, 2022, and October 1, 2021.

Table of Contents

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Revenue for the Company's operating and reportable segments disaggregated into geographic locations based on sales billed from the respective country and sales channels are as follows (in millions):


		Quarter Ended April 1, 2022										Quarter Ended September 30, 2022
		PSG			ASG		ISG		Total			PSG		ASG		ISG		Total
Geographic Location	Geographic Location										Geographic Location
Hong Kong											Hong Kong	$	351.2	$	192.7	$	74.0	$	617.9
Singapore	Singapore	$	280.5		$	233.8	$	41.4	$	555.7	Singapore	284.2		203.2		56.6		544.0
Hong Kong		303.1			173.9		52.6		529.6
United Kingdom	United Kingdom	186.9			106.6		52.0		345.5		United Kingdom	192.3		113.7		66.5		372.5
United States	United States	144.9			92.3		74.5		311.7		United States	208.1		117.3		90.0		415.4
Other	Other	71.3			82.7		48.5		202.5		Other	80.3		107.4		55.1		242.8
Total	Total	$	986.7		$	689.3	$	269.0	$	1,945.0	Total	$	1,116.1	$	734.3	$	342.2	$	2,192.6

Sales Channel	Sales Channel										Sales Channel
Distributors	Distributors	$	633.9		$	356.9	$	150.6	$	1,141.4	Distributors	$	726.0	$	368.1	$	187.4	$	1,281.5
Direct Customers	Direct Customers	352.8			332.4		118.4		803.6		Direct Customers	390.1		366.2		154.8		911.1

Total	Total	$	986.7		$	689.3	$	269.0	$	1,945.0	Total	$	1,116.1	$	734.3	$	342.2	$	2,192.6

				Nine Months Ended September 30, 2022
												PSG		ASG		ISG		Total
Geographic Location											Geographic Location
Hong Kong											Hong Kong	$	980.7	$	548.4	$	202.8	$	1,731.9
Singapore											Singapore	857.0		658.0		140.5		1,655.5
United Kingdom											United Kingdom	561.9		329.6		186.2		1,077.7
United States											United States	533.1		316.5		238.7		1,088.3
Other											Other	227.1		287.8		154.3		669.2
Total											Total	$	3,159.8	$	2,140.3	$	922.5	$	6,222.6

Sales Channel											Sales Channel
Distributors											Distributors	$	2,056.3	$	1,097.8	$	502.4	$	3,656.5
Direct Customers											Direct Customers	1,103.5		1,042.5		420.1		2,566.1

Total											Total	$	3,159.8	$	2,140.3	$	922.5	$	6,222.6

910

Table of Contents

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)


		Quarter Ended April 2, 2021										Quarter Ended October 1, 2021
		PSG			ASG		ISG		Total			PSG		ASG		ISG		Total
Geographic Location	Geographic Location										Geographic Location
Singapore	Singapore	$	274.5		$	201.7	$	32.8	$	509.0	Singapore	$	285.4	$	219.3	$	39.3	$	544.0
Hong Kong	Hong Kong	196.1			100.5		45.6		342.2		Hong Kong	281.8		152.2		53.0		487.0
United Kingdom	United Kingdom	142.7			82.6		43.6		268.9		United Kingdom	145.0		86.8		41.4		273.2
United States	United States	75.3			70.2		38.8		184.3		United States	115.8		74.3		48.6		238.7
Other	Other	58.4			76.5		42.4		177.3		Other	64.1		80.9		54.2		199.2
Total	Total	$	747.0		$	531.5	$	203.2	$	1,481.7	Total	$	892.1	$	613.5	$	236.5	$	1,742.1

Sales Channel	Sales Channel										Sales Channel
Distributors	Distributors	$	523.9		$	288.9	$	121.2	$	934.0	Distributors	$	644.2	$	355.6	$	149.0	$	1,148.8
Direct Customers	Direct Customers	223.1			242.6		82.0		547.7		Direct Customers	247.9		257.9		87.5		593.3

Total	Total	$	747.0		$	531.5	$	203.2	$	1,481.7	Total	$	892.1	$	613.5	$	236.5	$	1,742.1

				Nine Months Ended October 1, 2021
												PSG		ASG		ISG		Total
Geographic Location											Geographic Location
Singapore											Singapore	$	833.0	$	647.8	$	105.2	$	1,586.0
Hong Kong											Hong Kong	738.9		397.0		142.6		1,278.5
United Kingdom											United Kingdom	435.1		254.3		129.2		818.6
United States											United States	299.2		220.9		128.5		648.6
Other											Other	179.5		232.6��		149.9		562.0
Total											Total	$	2,485.7	$	1,752.6	$	655.4	$	4,893.7

Sales Channel											Sales Channel
Distributors											Distributors	$	1,779.2	$	988.8	$	410.7	$	3,178.7
Direct Customers											Direct Customers	706.5		763.8		244.7		1,715.0

Total											Total	$	2,485.7	$	1,752.6	$	655.4	$	4,893.7

The Company operates in various geographic locations. Sales to external customers have little correlation with the location of ~~manufacturers.~~end-customers. It is, therefore, not meaningful to present operating profit by geographical location. The Company does not discretely allocate assets to its operating segments, nor does management evaluate operating segments using discrete asset information. The Company’s consolidated assets are not specifically ascribed to its individual reportable segments. ~~Rather,~~Instead, assets used in operations are generally shared across the Company’s operating and reportable segments.

1011

Table of Contents

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Property, plant and equipment, net by geographic location, is summarized as follows (in millions):


		As of					As of
		April 1, 2022		December 31, 2021			September 30, 2022		December 31, 2021
United States	United States	$	752.4	$	767.1	United States	$	822.8	$	767.1
South Korea	South Korea	573.0		492.8		South Korea	737.6		492.8
Philippines	Philippines	330.7		342.4		Philippines	307.4		342.4
Czech Republic	Czech Republic	220.7		214.2		Czech Republic	248.3		214.2
China	China	214.0		216.8		China	204.5		216.8
Japan	Japan	188.1		198.6		Japan	135.6		198.6
Malaysia	Malaysia	172.8		175.3		Malaysia	181.0		175.3
Other	Other	107.7		117.1		Other	124.9		117.1
Total	Total	$	2,559.4	$	2,524.3	Total	$	2,762.1	$	2,524.3

Note 3: Recent Accounting Pronouncements and Other Developments

Adopted:

ASU 2020-06 - Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity ("ASU 2020-06")

In August 2020, the FASB issued ASU 2020-06, which simplifies the guidance on the issuer’s accounting for convertible debt instruments by removing the separation models for (1) convertible debt with a cash conversion feature and (2) convertible instruments with a beneficial conversion feature. Also, ASU 2020-06 requires the application of the if-converted method for the purpose of calculating diluted earnings per share, and the treasury stock method will be no longer available for instruments that fall under this category. The Company adopted ASU 2020-06 as of January 1, 2022 using the modified retrospective method, and recorded adjustments to reduce additional paid-in capital by $129.1 million and increase opening retained earnings by $27.1 million to reflect the cumulative effect of the adoption. See Note 7:8: ''Long-Term Debt'' for further information.

Pending adoption:

ASU 2021-10 - Government Assistance (Topic 832) - Disclosures by Business Entities about Government Assistance ("ASU 2021-10")

In November 2021, the FASB issued ASU 2021-10, which requires business entities to make annual disclosures about the nature of ~~the~~ certain government assistance received, ~~and~~ the related accounting ~~policy~~policies used to account for ~~such assistance along with certain other disclosures related to~~ the ~~transactions. If an entity omits any required disclosures because it is legally prohibited, it must disclose that fact. ASU 2021-10 will be applicable to~~transactions, the ~~2022 annual~~effect of the transactions on company financial statements and the significant terms and conditions of the transactions. The Company is ~~currently~~planning to complete the required ASU 2021-10 disclosures with the filing of its Annual Report on Form 10-K for the year ending on December 31, 2022.

Recent Legislation

CHIPS Act

On August 9, 2022, the CHIPS and Science Act of 2022, H.R. 4346 (the “CHIPS Act”) was signed into law. The CHIPS Act provides for a 25% refundable tax credits on certain investments in domestic semiconductor manufacturing. The credit is provided for qualifying property, which is placed in service after December 31, 2022. The CHIPS Act also provides for certain other financial incentives to further investments in domestic semiconductor manufacturing. The Company is evaluating the ~~applicable disclosures.~~provisions of the new law and its potential impact to the Company.

1112

Table of Contents

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Inflation Reduction Act

On August 16, 2022, the Inflation Reduction Act of 2022, H.R. 5376 (the “IRA”), was signed into law. The IRA introduces a 15% CAMT for corporations whose average annual adjusted financial statement income for any consecutive three-tax-year period preceding the applicable tax year exceeds $1 billion and a 1% excise tax on certain stock repurchases The CAMT and the excise tax are effective in taxable years beginning after December 31, 2022. The Company is evaluating the provisions of the new law and its potential impact to the Company.

Note 4: Acquisition and Divestitures

Acquisition:

The Company finalized its determination relating to the fair value of assets acquired and liabilities assumed from ~~GTAT.~~GTAT during the quarter ended April 1, 2022. The final allocation of the purchase price, which did not change from the preliminary allocation disclosed in the 2021 Form 10-K is as follows (in millions):


	Purchase Price Allocation
Cash and cash equivalents	$	8.2
Inventory and other current assets	10.0
Property, plant and equipment	31.9
Goodwill	274.8
Intangible assets - Developed Technology	130.0
Deferred tax assets	13.4
Other non-current assets	7.4
Total assets acquired	475.7
Current liabilities	5.8
Other long-term liabilities	35.0
Total liabilities assumed	40.8
Net assets acquired/purchase price	$	434.9

All assumptions and disclosures remained unchanged from the amounts included in the 2021 Form 10-K.

Divestitures:

~~Belgium fab~~

In February 2022, the Company divested its Oudenaarde, Belgium site to BelGaN Group BV, which primarily included the assets, liabilities and relevant employee group related to the six-inch front-end wafer manufacturing facility for an aggregate consideration of $19.9 million and recognized a nominal gain after offsetting the carrying values of the assets disposed and liabilities transferred.

~~South Portland, Maine fab~~

During the first quarter of 2022, the Company ~~entered into~~divested its six-inch front-end wafer manufacturing facility in Oudenaarde, Belgium, to BelGaN Group BV for an ~~asset purchase agreement to divest~~aggregate consideration of approximately $19.9 million.

During the second quarter of 2022, the Company completed the divestiture of its ~~South Portland, Maine site to Diodes Incorporated, which includes the net assets and relevant employee group related to the~~ eight-inch front-end wafer manufacturing ~~facility.~~facility in South Portland, Maine to Diodes Incorporated for an aggregate consideration of approximately $80.0 million. Additionally, during the second quarter of 2022, the Company divested its non-strategic GTAT Sapphire business in Salem, Massachusetts to Crystal Systems, LLC for nominal consideration. These divestiture transactions resulted in a gain on divestiture of approximately $1.9 million.

The Company has signed wafer supply agreements with the buyers of the Belgium and South Portland, Maine manufacturing facilities.

During the third quarter of 2022, the Company entered into an Asset Purchase Agreement with LA Semiconductor to divest its wafer manufacturing facility in Pocatello, Idaho for an aggregate consideration of approximately $80.0 million. The transaction closed on October 14, 2022.

During the third quarter of 2022, the Company entered into a Stock Purchase Agreement with JS Foundry K.K., a Japanese based foundry company, to divest its wafer manufacturing facility in Niigata, Japan. The transaction is expected to close as soon as regulatory approvals are received and closing conditions are met.

Table of Contents

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

As of September 30, 2022, approximately $49.5 million and $81.9 million of assets were reclassified as Assets held-for-sale, related to the divestiture of the wafer manufacturing facilities in Pocatello, Idaho and Niigata, Japan, respectively. Approximately $37.3 million of liabilities were reclassified as Liabilities held-for-sale related to the divestiture of the Niigata, Japan facility.

Note 5: Goodwill and Intangible Assets

Goodwill

During the third quarter of 2022, the Company approved an exit plan to wind down its QCS division within ASG that is generally associated with the Company’s legacy Quantenna division, representing less than 3.0% of the Company's consolidated revenue for 2021. This exit plan constituted a change in circumstances (a “triggering event”). The Company determined that it was appropriate to evaluate the long-lived assets and assigned goodwill for impairment. The division, which is also a reporting unit for purposes of evaluating the recoverability of goodwill, had an assigned goodwill balance of approximately $215.0 million and an unamortized intangible assets balance of approximately $58.0 million as of the exit plan approval date.

The Company determined that the discounted cash flow method under the income approach was the most appropriate method to evaluate the recoverability of the carrying value of the reporting unit's net assets. During the quarter ended September 30, 2022, management performed an event-triggered impairment analysis and determined that the remaining balance of goodwill and unamortized intangible assets totaling $215.0 million and $56.8 million, respectively, was impaired.

Previously, during the second quarter of 2022, ~~and result~~management performed an event-triggered impairment analysis, which resulted in a ~~nominal gain or loss,~~partial impairment of the QCS division's goodwill amounting to $115.0 million. For this impairment, the Company determined that a market approach was the most appropriate method to evaluate the recoverability of the carrying value of the net assets of the reporting unit, as the Company was attempting to sell this reporting unit to an interested party due to the Company's focus on its long-term product mix into its strategic markets.

During the nine months ended September 30, 2022, approximately $386.8 million of impairment charges was recorded under the caption ‘Goodwill and intangible asset impairment’ within the Consolidated Statements of Operations and Comprehensive Income.

The following table summarizes goodwill by operating and reportable segments (in millions):


	As of
	September 30, 2022				December 31, 2021
	Goodwill		Accumulated Impairment Losses		Carrying Value		Goodwill		Accumulated Impairment Losses		Carrying Value
Operating and Reportable Segments:
PSG	$	708.0	$	(31.9)	$	676.1	$	708.0	$	(31.9)	$	676.1
ASG	1,559.2		(748.9)		810.3		1,566.3		(418.9)		1,147.4
ISG	114.0		—		114.0		114.0		—		114.0
	$	2,381.2	$	(780.8)	$	1,600.4	$	2,388.3	$	(450.8)	$	1,937.5

Table of Contents

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Changes in the goodwill balance from December 31, 2021 to September 30, 2022 related to the ASG reporting unit impairment and the ~~corresponding~~divestiture of the Belgium and South Portland, Maine manufacturing facilities, and were as follows (in millions):


Net balance as of December 31, 2021	$	1,937.5

Goodwill impairment	(330.0)
Goodwill disposed	(7.1)
Net balance as of September 30, 2022	$	1,600.4

Intangible Assets

Intangible assets, ~~have been classified~~net, were as ~~held~~follows (in millions):


	As of September 30, 2022
	Original Cost		Accumulated Amortization		Accumulated Impairment Losses		Carrying Value
Customer relationships	$	581.5	$	(454.7)	$	(36.3)	$	90.5
Developed technology	939.6		(645.1)		(40.7)		253.8

Licenses	30.0		(1.3)		—		28.7
Other intangibles	79.1		(63.1)		(15.2)		0.8
Total intangible assets	$	1,630.2	$	(1,164.2)	$	(92.2)	$	373.8


	As of December 31, 2021
	Original Cost		Accumulated Amortization		Accumulated Impairment Losses		Carrying Value
Customer relationships	$	581.5	$	(436.3)	$	(17.6)	$	127.6
Developed technology	928.1		(600.5)		(2.6)		325.0

Licenses	30.0		(0.3)		—		29.7
Other intangibles	79.1		(62.1)		(15.2)		1.8
Total intangible assets	$	1,618.7	$	(1,099.2)	$	(35.4)	$	484.1

Not included in the above table are the value of IPRD projects amounting to $11.6 million as of December 31, 2021. During the nine months ended September 30, 2022, the Company completed its remaining IPRD projects resulting in the reclassification of $11.6 million from IPRD to developed technology.

Amortization expense for ~~sale within other current assets.~~intangible assets is expected to be as follows for the remainder of 2022, each of the next four years and thereafter (in millions):


Period	Amortization Expense
Remainder of 2022	$	17.7
2023	56.8
2024	58.1
2025	47.9
2026	41.6
Thereafter	151.7
Total	$	373.8

Table of Contents

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Note 5:6: Restructuring, Asset Impairments and Other, Net

Details of restructuring, asset impairments and other charges, net are as follows (in millions):


		Restructuring		Asset Impairments		Other		Total			Restructuring		Asset Impairments		Other			Total
Quarter ended April 1, 2022

Quarter ended September 30, 2022										Quarter ended September 30, 2022
QCS wind down										QCS wind down	$	12.7	$	18.6	$	25.9	(3)	$	57.2

Other(1)	Other(1)	$	(0.5)	$	4.0	$	(16.5)	$	(13.0)	Other(1)	$	(0.1)	$	—	$	(16.8)		$	(16.9)
Total	Total	$	(0.5)	$	4.0	$	(16.5)	$	(13.0)	Total	$	12.6	$	18.6	$	9.1		$	40.3

											Restructuring		Asset Impairments		Other			Total
Nine months ended September 30, 2022										Nine months ended September 30, 2022
QCS wind down										QCS wind down	$	12.7	$	18.6	$	25.9	(3)	$	57.2

Other (2)										Other (2)	$	(1.3)	$	4.0	$	(34.3)		$	(31.6)
Total										Total	$	11.4	$	22.6	$	(8.4)		$	25.6

(1)Primarily includes a gain of approximately $17.3 million from the sale of the Company headquarters location in Phoenix, Arizona (the "Corporate Headquarters") completed during the third quarter of 2022 offset by approximately $0.5 million related to litigation charges.

(2)Primarily includes a gain of approximately $34.8 million related to the sale of two office buildings and the sale of the Corporate Headquarters, and a $1.3 million reduction in workforce restructuring expense offset by a $4.0 million asset impairment of the GTAT Sapphire business, and approximately $0.5 million related to litigation charges.

(3)Primarily relates to contract cancellation charges of approximately $15.4 million and legal charges of $10.5 million.

A summary of changes in accrued restructuring balance is as follows (in millions):


	As of						As of
	December 31, 2021		Charges		Usage		September 30, 2022
Employee separation charges	$	10.8	$	11.4	$	(10.6)	$	11.6

Total	$	10.8	$	11.4	$	(10.6)	$	11.6

QCS wind down

On September 16, 2022, the Company's Board of Directors approved an exit plan to wind down the QCS division as part of its ongoing efforts to focus on growth drivers and key markets, and to streamline its operations. As part of the exit plan, during the third quarter of 2022, the Company notified approximately 330 employees of their employment termination and incurred severance costs and other benefits of approximately $12.7 million. Substantially all the employees will leave the Company during the fourth quarter of 2022.

As of September 30, 2022, $10.4 million of severance costs and other benefits remained accrued and, based on the exit dates of the notified employees, is expected to be paid during the fourth quarter of 2022.

In connection with the exit plan, the Company recorded $25.9 million of exit costs, which primarily relates to litigation and contract cancellation charges. The Company impaired $8.0 million of Property, Plant and Equipment as well as $10.6 million of other miscellaneous assets. The Company recorded inventory reserves associated with the QCS wind down of $28.0 million.

Other

The additional activity during the quarter and nine months ended September 30, 2022 represented payments to employees whose employment was terminated during 2021. The Company expects to pay the remaining accrued expense during the fourth quarter of 2022.

1216

Table of Contents

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

~~A summary of changes in accrued restructuring balance is as follows (in millions):~~

As of As of
December 31, 2021 Charges Usage April 1, 2022
Employee separation charges $ 10.8 $ (0.5) $ (4.8) $ 5.5
Total $ 10.8 $ (0.5) $ (4.8) $ 5.5

The Other category primarily includes the gain from the sale of an office building. There were no new restructuring programs implemented and the activity during the quarter ended April 1, 2022 represented payments to employees whose employments were terminated during 2021.

The Company continues to evaluate employee positions and locations for potential efficiencies and may incur additional charges in the future.

Note 6:7: Balance Sheet Information and Other

~~Goodwill~~

~~There was an insignificant change in the balance of goodwill from December 31, 2021 to April 1, 2022 relating to the divestiture of a business.~~

Goodwill is tested for impairment annually on the first day of the fourth quarter or more frequently if events or changes in circumstances (each, a "triggering event") would more likely than not reduce the carrying value of goodwill below its fair value. Management did not identify any triggering events during the quarter ended April 1, 2022 that would require an interim impairment analysis.

Inventory

Details of Inventory included in the Company’s Consolidated Balance Sheets are as follows (in millions):
As of
April 1, 2022 December 31, 2021
Inventories:
Raw materials $ 193.5 $ 174.2
Work in process 971.5 888.9
Finished goods 331.0 316.4
$ 1,496.0 $ 1,379.5

~~Other current assets~~

Assets classified as held-for-sale, consisting of properties and certain other assets, are required to be recorded at the lower of carrying value or fair value less costs to sell. Fixed assets of approximately $70 million have been classified as held-for-sale within other current assets as of April 1, 2022.


	As of
	September 30, 2022		December 31, 2021
Inventories:
Raw materials	$	203.1	$	174.2
Work in process	962.2		888.9
Finished goods	410.1		316.4
	$	1,575.4	$	1,379.5

Defined Benefit Plans

The Company recognizes the aggregate amount of all over-funded plans as assets and the aggregate amount of all underfunded plans as liabilities in its financial statements. As of ~~April 1,~~September 30, 2022, the net assets for the over-funded plans totaled $~~14.3 million.~~12.8 million of which, approximately $3.7 million was reclassified to Assets held-for-sale related to the divestiture of the wafer manufacturing facility in Niigata, Japan. The total accrued pension liability for underfunded plans was ~~$112.6~~$100.4 million, of which the current portion of ~~$0.2~~$0.3 million was classified as accrued expenses and other current ~~liabilities.~~liabilities and approximately $20.8 million was reclassified to Liabilities held-for-sale related to the divestiture of the wafer manufacturing facility in Niigata, Japan. As of December 31, 2021, the net funded status for all the plans was a liability of $103.9 million, of which the current portion of $0.2 million was classified as accrued expenses and other current liabilities.

The components of the net periodic pension expense were as follows (in millions):

~~Table of Contents~~

~~ON SEMICONDUCTOR CORPORATION~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued~~

~~(unaudited)~~


		Quarters Ended				Quarters Ended				Nine Months Ended
		April 1, 2022		April 2, 2021				September 30, 2022		October 1, 2021		September 30, 2022		October 1, 2021
Service cost	Service cost	$	2.2	$	3.1		Service cost	$	2.2	$	2.8	$	6.6	$	8.9
Interest cost	Interest cost	1.1		1.1			Interest cost	1.0		1.1		3.1		3.3
Expected return on plan assets	Expected return on plan assets	(1.2)		(1.7)			Expected return on plan assets	(1.1)		(1.6)		(3.4)		(4.9)

Curtailment loss		—		1.9
Curtailment gain							Curtailment gain	—		(2.3)		—		(0.4)

Total net periodic pension cost	Total net periodic pension cost	$	2.1	$	4.4		Total net periodic pension cost	$	2.1	$	—	$	6.3	$	6.9

Leases

Operating lease arrangements are comprised primarily of real estate and equipment agreements. The components of lease expense were as follows (in millions):


		Quarters Ended				Quarters Ended				Nine Months Ended
		April 1, 2022		April 2, 2021				September 30, 2022		October 1, 2021		September 30, 2022		October 1, 2021
Operating lease	Operating lease	$	11.2	$	9.9		Operating lease	$	12.4	$	9.8	$	35.3	$	29.6
Variable lease	Variable lease	1.6		1.0			Variable lease	1.8		0.9		7.5		2.9
Short-term lease	Short-term lease	0.4		0.7			Short-term lease	0.9		0.4		2.1		1.6
Total lease expense	Total lease expense	$	13.2	$	11.6		Total lease expense	$	15.1	$	11.1	$	44.9	$	34.1

~~The lease liabilities recognized in the Consolidated Balance Sheets are as follows (in millions):~~

As of
April 1, 2022 December 31, 2021
Operating lease liabilities included in:
Accrued expenses and other current liabilities $ 35.1 $ 32.5
Other long-term liabilities 137.9 142.4
Total $ 173.0 $ 174.9
Operating ROU assets included in:
Other assets $ 169.7 $ 170.1
Financing lease liabilities included in:
Accrued expenses and other current liabilities $ 12.7 $ 12.7
Other long-term liabilities 10.2 10.2
Total $ 22.9 $ 22.9
Financing ROU assets included in:
Other assets $ 21.9 $ 22.3

As of April 1, 2022, the weighted-average remaining lease-terms were 8.3 years and 19.8 years and the weighted-average discount rates were 4.2% and 6.0% for operating and financing leases, respectively.

~~Supplemental Disclosure of Cash Flow Information~~

1417

Table of Contents

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

The ROU assets and lease liabilities recognized in the Consolidated Balance Sheets are as follows (in millions):


	As of
	September 30, 2022		December 31, 2021
Operating lease liabilities included in:
Accrued expenses and other current liabilities	$	33.1	$	32.5
Other long-term liabilities	203.0		142.4
Total	$	236.1	$	174.9

Operating ROU assets included in:
Other assets	$	222.3	$	170.1

Financing lease liabilities included in:
Accrued expenses and other current liabilities	$	11.6	$	12.7
Other long-term liabilities	20.6		10.2
Total	$	32.2	$	22.9
Financing ROU assets included in:
Other assets	$	46.4	$	22.3

As of September 30, 2022, the weighted-average remaining lease-terms were 10.6 years and 19.3 years, and the weighted-average discount rates were 4.7% and 6.0% for operating and financing leases, respectively.

New Leases

During the second quarter of 2022, the Company entered into leases and related agreements to lease space for a new corporate headquarters in Arizona and new office space in California. The Company recorded cumulative ROU assets and liabilities of $70.7 million.

Supplemental Disclosure of Cash Flow Information

Certain of the Company's cash and non-cash activities were as follows (in millions):


		Quarters Ended				Nine Months Ended
		April 1, 2022		April 2, 2021				September 30, 2022		October 1, 2021
Non-cash investing activities:	Non-cash investing activities:						Non-cash investing activities:
Capital expenditures in accounts payable and other long-term liabilities	Capital expenditures in accounts payable and other long-term liabilities	$	225.4	$	180.9		Capital expenditures in accounts payable and other long-term liabilities	$	253.5	$	153.3

Divestiture/Sale of property in exchange of receivable							Divestiture/Sale of property in exchange of receivable	—		9.1
Operating ROU assets obtained in exchange of lease liabilities	Operating ROU assets obtained in exchange of lease liabilities	10.7		7.1			Operating ROU assets obtained in exchange of lease liabilities	90.6		14.2

Cash paid for:	Cash paid for:						Cash paid for:

Interest expense	Interest expense	$	24.0	$	31.4		Interest expense	$	62.8	$	80.7
Income taxes	Income taxes	15.7		20.9			Income taxes	329.5		65.1
Operating lease payments in operating cash flows	Operating lease payments in operating cash flows	11.0		10.3			Operating lease payments in operating cash flows	31.8		30.6

Table of Contents

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Reconciliation of the captions in the Consolidated Balance Sheets to the Consolidated Statements of Cash Flows (in millions):


		As of									As of
		April 1, 2022		December 31, 2021		April 2, 2021		December 31, 2020			September 30, 2022		December 31, 2021		October 1, 2021		December 31, 2020
Consolidated Balance Sheets:	Consolidated Balance Sheets:									Consolidated Balance Sheets:
Cash and cash equivalents	Cash and cash equivalents	$	1,645.1	$	1,352.6	$	1,042.5	$	1,080.7	Cash and cash equivalents	$	2,450.2	$	1,352.6	$	1,389.2	$	1,080.7
Restricted cash (included in other current assets)	Restricted cash (included in other current assets)	18.8		20.1		1.4		0.8		Restricted cash (included in other current assets)	17.2		20.1		1.4		0.8
Restricted cash (included in other non-current assets)	Restricted cash (included in other non-current assets)	5.0		5.0		—		—		Restricted cash (included in other non-current assets)	5.0		5.0		—		—
Cash, cash equivalents and restricted cash in Consolidated Statements of Cash Flows	Cash, cash equivalents and restricted cash in Consolidated Statements of Cash Flows	$	1,668.9	$	1,377.7	$	1,043.9	$	1,081.5	Cash, cash equivalents and restricted cash in Consolidated Statements of Cash Flows	$	2,472.4	$	1,377.7	$	1,390.6	$	1,081.5

As of ~~April 1,~~September 30, 2022, $15.0 million of the restricted cash balance was held in escrow relating to the acquisition of GTAT and will be released to the former stockholders of GTAT upon satisfaction of certain outstanding items contained in the acquisition agreement.

Note 7:8: Long-Term Debt

The Company's long-term debt consists of the following (annualized interest rates, dollars in millions):


		As of					As of
		April 1, 2022		December 31, 2021			September 30, 2022		December 31, 2021
Amended Credit Agreement:	Amended Credit Agreement:					Amended Credit Agreement:

Term Loan "B" Facility due 2026, interest payable monthly at 2.46% and 2.10%, respectively		1,594.1		1,598.2
Revolving Credit Facility due 2024, interest payable monthly at 4.37% and —%, respectively						Revolving Credit Facility due 2024, interest payable monthly at 4.37% and —%, respectively	$	500.0	$	—
Term Loan "B" Facility due 2026, interest payable monthly at 5.12% and 2.10%, respectively						Term Loan "B" Facility due 2026, interest payable monthly at 5.12% and 2.10%, respectively	1,088.7		1,598.2
0% Notes due 2027	0% Notes due 2027	805.0		805.0		0% Notes due 2027	805.0		805.0
3.875% Notes due 2028 (1)	3.875% Notes due 2028 (1)	700.0		700.0		3.875% Notes due 2028 (1)	700.0		700.0

1.625% Notes due 2023 (2)	1.625% Notes due 2023 (2)	155.1		155.1		1.625% Notes due 2023 (2)	155.1		155.1
Gross long-term debt, including current maturities	Gross long-term debt, including current maturities	$	3,254.2	$	3,258.3	Gross long-term debt, including current maturities	$	3,248.8	$	3,258.3
Less: Debt discount (3)	Less: Debt discount (3)	(12.6)		(149.0)		Less: Debt discount (3)	(9.5)		(149.0)
Less: Debt issuance costs (4)	Less: Debt issuance costs (4)	(35.8)		(34.7)		Less: Debt issuance costs (4)	(27.5)		(34.7)
Net long-term debt, including current maturities	Net long-term debt, including current maturities	$	3,205.8	$	3,074.6	Net long-term debt, including current maturities	$	3,211.8	$	3,074.6
Less: Current maturities	Less: Current maturities	(170.4)		(160.7)		Less: Current maturities	(165.3)		(160.7)
Net long-term debt	Net long-term debt	$	3,035.4	$	2,913.9	Net long-term debt	$	3,046.5	$	2,913.9

(1)Interest is payable on March 1 and September 1 of each year at 3.875% annually.

(2)Interest is payable on April 15 and October 15 of each year at 1.625% annually.

~~Table of Contents~~

~~ON SEMICONDUCTOR CORPORATION~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued~~

~~(unaudited)~~

(3)Debt discount of ~~$7.2~~$4.4 million and $7.5 million for the Term Loan "B" Facility and ~~$5.4~~$5.1 million and $5.8 million for the 3.875% Notes, in each case as of ~~April 1,~~September 30, 2022 and December 31, 2021, respectively. Debt discount of $126.1 million for the 0% Notes and $9.6 million for the 1.625% Notes, in each case as of December 31, 2021. No debt discount as of ~~April 1,~~September 30, 2022 for the 0% Notes and the 1.625% Notes due to the adoption of ASU 2020-06.

(4)Debt issuance costs of ~~$16.8~~$10.3 million and $17.7 million for the Term Loan "B" Facility, ~~$16.3~~$14.7 million and $14.1 million for the 0% Notes, ~~$1.9~~$1.8 million and $2.0 million for the 3.875% Notes and ~~$0.8~~$0.6 million and $0.9 million for the 1.625% Notes, in each case as of ~~April 1,~~September 30, 2022 and December 31, 2021, respectively.

Table of Contents

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Expected maturities of gross long-term debt (including current portion - see section regarding 1.625% Notes below) as of ~~April 1,~~September 30, 2022 were as follows (in millions):


Period	Period	Expected Maturities		Period	Expected Maturities
Remainder of 2022	Remainder of 2022	$	167.4	Remainder of 2022	$	157.9
2023	2023	16.3		2023	10.9
2024	2024	16.3		2024	511.0
2025	2025	16.3		2025	10.9
2026	2026	1,532.9		2026	1,053.1
Thereafter	Thereafter	1,505.0		Thereafter	1,505.0
Total	Total	$	3,254.2	Total	$	3,248.8

The Company was in compliance with its covenants under all debt agreements as of ~~April 1,~~September 30, 2022.

Borrowings and Repayments under the Amended Credit Agreement

During the second quarter of 2022, the Company borrowed $500.0 million under the Revolving Credit Facility. These proceeds were used to prepay $500.0 million of borrowings under the Term Loan “B” Facility. The Company expensed $7.3 million of unamortized debt discount and issuance costs attributed to the partial pay-down as loss on debt refinancing and prepayment. As of September 30, 2022, the Company had approximately $1.5 billion available under the Revolving Credit Facility for future borrowings.

Adoption of ASU 2020-06

As described in Note 3: ~~Recent~~''Recent Accounting Pronouncements and Other Developments,'' the Company adopted ASU 2020-06 using a modified retrospective method and increased long-term debt by eliminating debt discount of $135.7 million, reduced additional paid-in capital by $129.1 million and increased opening retained earnings by $27.1 million to reflect the cumulative effect of adoption as of January 1, 2022. The application of the if-converted method to determine the net income for diluted earnings and diluted weighted-average shares of common stock outstanding did not have a meaningful impact on the diluted net income per share of common stock under the treasury stock method previously applied.

1.625% Notes due 2023

The remaining outstanding principal amount of the 1.625% Notes, amounting to $155.1 million, net of unamortized issuance costs, ~~continues~~continued to be classified as a current portion of long-term debt as of ~~April 1,~~September 30, 2022. Pursuant to the indenture governing the 1.625% Notes, because the last reported sale price of the Company’s common stock for at least 20 trading days during the period of 30 consecutive trading days ending on ~~March 31,~~September 30, 2022 was greater than or equal to $26.94 (130% of the conversion price) on each applicable trading day, the holders have the right to surrender any portion of their 1.625% Notes (in minimum denominations of $1,000 in principal amount or an integral multiple thereof) for conversion during the calendar quarter ending ~~June 30,~~December 31, 2022, and only during such calendar quarter.

Table of Contents

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Note 8:9: Earnings Per Share and Equity

Earnings Per Share

Net income per share of common stock for calculating basic and diluted earnings per share is calculated as follows (in millions, except per share data):


		Quarters Ended				Quarters Ended				Nine Months Ended
		April 1, 2022		April 2, 2021				September 30, 2022		October 1, 2021		September 30, 2022		October 1, 2021
Net income for basic earnings per share of common stock	Net income for basic earnings per share of common stock	$	530.2	$	89.9		Net income for basic earnings per share of common stock	$	311.9	$	309.7	$	1,297.9	$	583.7
Add: Interest on 1.625% Notes	Add: Interest on 1.625% Notes	0.5		—			Add: Interest on 1.625% Notes	0.5		—		1.5		—
Net income for diluted earnings per share of common stock	Net income for diluted earnings per share of common stock	$	530.7	$	89.9		Net income for diluted earnings per share of common stock	$	312.4	$	309.7	$	1,299.4	$	583.7

Basic weighted-average shares of common stock outstanding	Basic weighted-average shares of common stock outstanding	433.3		413.4			Basic weighted-average shares of common stock outstanding	432.9		430.6		433.5		423.8
Dilutive effect of share-based awards	Dilutive effect of share-based awards	2.4		2.7			Dilutive effect of share-based awards	1.6		2.3		1.8		2.3
Dilutive effect of convertible notes and warrants	Dilutive effect of convertible notes and warrants	13.2		29.3			Dilutive effect of convertible notes and warrants	14.2		7.8		13.0		17.0
Diluted weighted-average shares of common stock outstanding	Diluted weighted-average shares of common stock outstanding	448.9		445.4			Diluted weighted-average shares of common stock outstanding	448.7		440.7		448.3		443.1

Net income per share of common stock:	Net income per share of common stock:						Net income per share of common stock:
Basic	Basic	$	1.22	$	0.22		Basic	$	0.72	$	0.72	$	2.99	$	1.38
Diluted	Diluted	$	1.18	$	0.20		Diluted	$	0.70	$	0.70	$	2.90	$	1.32

Basic income per share of common stock is computed by dividing net income for basic earnings by the weighted-average number of shares of common stock outstanding during the period. To calculate the diluted weighted-average shares of common stock outstanding, the treasury stock method has been applied to calculate the number of incremental shares from the assumed issuance of shares relating to RSUs. The excluded number of anti-dilutive share-based awards was ~~approximately~~zero and 0.2 ~~million and 0.7~~ million for the quarters ended ~~April 1,~~September 30, 2022 and ~~April 2,~~October 1, 2021, respectively, and 0.4 million for the nine months ended September 30, 2022 and October 1, 2021, respectively.

The dilutive impacts related to the 0% Notes and 1.625% Notes have been calculated using the if-converted ~~method.~~method for the quarter and nine months ended September 30, 2022 and using the treasury stock method for the quarter and nine months ended October 1, 2021. While the 0% Notes are repayable in cash up to the par value and in cash or shares of common stock for the excess over par value, the 1.625% Notes are repayable in cash or shares of common stock for their entire value. Prior to conversion, the convertible note hedges are not considered for purposes of the earnings per share calculations, as their effect would be anti-dilutive. Upon conversion, the convertible note hedges are expected to offset the dilutive effect of the 0% Notes and 1.625% Notes when the stock price is above $52.97 and $20.72 per share, respectively.

The dilutive impact of the warrants issued concurrently with the issuance of the 0% Notes and 1.625% Notes with exercise prices of $74.34 and $30.70, respectively, has been included in the calculation of diluted weighted-average common shares outstanding, if applicable.

Equity

Share Repurchase Program

Under the Company's share repurchase program announced on November 15, 2018 (the "Share Repurchase Program"), the Company may repurchase up to $1.5 billion (exclusive of fees, commissions and other expenses) of the Company's common stock from December 1, 2018 through December 31, 2022.

The Company repurchased approximately 1.2 million and 2.7 million shares of common stock for an aggregate purchase price of $80.1 million and $169.8 million, respectively, during the quarter and nine months ended September 30, 2022. There were no repurchases during the ~~quarters~~quarter and nine months ended ~~April~~October 1, ~~2022 and April 2,~~ 2021 under the Share Repurchase Program. As of ~~April 1,~~September 30, 2022, the authorized amount remaining under the Share Repurchase Program was ~~$1,295.8~~$1,126.1 million.

Table of Contents

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Shares for Restricted Stock Units Tax Withholding

The amounts remitted for employee withholding taxes during the ~~quarters~~quarter and nine months ended ~~April 1,~~September 30, 2022 ~~and April 2, 2021~~ were ~~$58.8~~$4.1 million and ~~$28.5~~$67.4 million, respectively, for which the Company withheld approximately ~~1.0~~0.1 million and ~~0.7~~1.1 million shares of

~~Table~~ common stock, respectively, that were underlying the RSUs that vested. The amounts remitted during the quarter and nine months ended October 1, 2021 were $2.2 million and $34.2 million, respectively, for which the Company withheld approximately 0.1 million and 0.9 million shares of ~~Contents~~

~~ON SEMICONDUCTOR CORPORATION~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued~~

~~(unaudited)~~

common stock, respectively, that were underlying the RSUs that vested. None of these shares had been reissued or retired as of ~~April 1,~~September 30, 2022 but may be reissued or retired in the future. These deemed repurchases in connection with tax withholding upon vesting were not made under the Share Repurchase Program, and the amounts spent in connection with such deemed repurchases did not reduce the authorized amount remaining under the Share Repurchase Program.

Non-Controlling Interest in Leshan-Phoenix Semiconductor Company Limited (“Leshan”)

The results of Leshan have been consolidated in the Company's financial statements. As of December 31, 2021, the non-controlling interest balance was $19.0 million and, along with the ~~$0.8~~$1.6 million share of the earnings for the ~~quarter~~nine months ended ~~April 1,~~September 30, 2022, increased to ~~$19.8~~$20.6 million as of ~~April 1,~~September 30, 2022.

Note 9:10: Share-Based Compensation

Total share-based compensation expense related to the Company's RSUs, stock grant awards and the ESPP was recorded within the Consolidated Statements of Operations and Comprehensive Income as follows (in millions):


		Quarters Ended				Quarters Ended				Nine Months Ended
		April 1, 2022		April 2, 2021				September 30, 2022		October 1, 2021		September 30, 2022		October 1, 2021
Cost of revenue	Cost of revenue	$	2.6	$	3.3		Cost of revenue	$	3.2	$	3.6	$	8.9	$	11.8
Research and development	Research and development	4.4		5.7			Research and development	4.9		5.4		14.5		18.4
Selling and marketing	Selling and marketing	3.8		4.3			Selling and marketing	4.1		3.7		12.2		12.5
General and administrative	General and administrative	11.7		9.0			General and administrative	14.7		10.0		40.9		31.4
Share-based compensation expense	Share-based compensation expense	$	22.5	$	22.3		Share-based compensation expense	$	26.9	$	22.7	$	76.5	$	74.1
Income tax benefit	Income tax benefit	(4.7)		(4.7)			Income tax benefit	(5.6)		(4.8)		(16.1)		(15.6)
Share-based compensation expense, net of taxes	Share-based compensation expense, net of taxes	$	17.8	$	17.6		Share-based compensation expense, net of taxes	$	21.3	$	17.9	$	60.4	$	58.5

As of ~~April 1,~~September 30, 2022, total unrecognized expected share-based compensation expense, net of estimated forfeitures, related to non-vested RSUs with service, performance and market conditions was ~~$157.6~~$122.7 million, which is expected to be recognized over a weighted-average period of ~~1.8~~1.4 years. Upon vesting of RSUs, stock grant awards or completion of a purchase under the ESPP, the Company issues new shares of common stock. The annualized pre-vesting forfeiture rate for RSUs was estimated to be 8% for the quarter and nine months ended September 30, 2022 and 6% for the quarter and nine months ended ~~April~~October 1, ~~2022 and 5% for the quarter ended April 2,~~ 2021.

Shares Available

As of ~~April 1,~~September 30, 2022 and December 31, 2021, there was an aggregate of 39.9 million and 42.2 million shares of common stock, respectively, available for grant under the Amended and Restated SIP.

Restricted Stock Units

RSUs generally vest ratably over three years for awards with service conditions and over two or three years for awards with performance or market conditions, or a combination thereof, and are settled in shares of the Company's common stock upon vesting. A summary of the RSU transactions for the ~~quarter~~nine months ended ~~April 1,~~September 30, 2022 is as follows (in millions, except per share data):

Number of Shares Weighted-Average Grant Date Fair Value Per Share
Non-vested RSUs at December 31, 2021 6.2 $ 28.60
Granted 1.5 60.66
Achieved 0.2 41.35
Released (2.9) 25.19
Forfeited (0.2) 32.66
Non-vested RSUs at April 1, 2022 4.8 40.83

1822

Table of Contents

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)


	Number of Shares	Weighted-Average Grant Date Fair Value Per Share
Non-vested RSUs at December 31, 2021	6.2	$	28.60
Granted	1.8	60.41
Achieved	0.2	41.35
Released	(3.4)	25.27
Forfeited	(0.5)	38.57
Non-vested RSUs at September 30, 2022	4.3	43.87

Note ~~10:~~11: Commitments and Contingencies

Environmental Contingencies

There are no new material environmental contingencies subsequent to the filing of the 2021 Form 10-K.

Financing Contingencies

In the ordinary course of business, the Company provides standby letters of credit or other guarantee instruments to certain parties initiated by either the Company or its subsidiaries, as required for transactions, including, but not limited to, material purchase commitments, agreements to mitigate collection risk, leases, utilities or customs guarantees. As of ~~April 1,~~September 30, 2022, the Company's Revolving Credit Facility included $15.0 million available for the issuance of letters of credit. There were $0.9 million in letters of credit outstanding under the Revolving Credit Facility as of ~~April 1,~~September 30, 2022, which reduced the Company's borrowing capacity. As of ~~April 1,~~September 30, 2022, the Company also had outstanding guarantees and letters of credit outside of its Revolving Credit Facility totaling ~~$13.4~~$17.0 million.

As part of obtaining financing in the ordinary course of business, the Company issued guarantees related to certain of its subsidiaries, which totaled $0.9 million as of ~~April 1,~~September 30, 2022. Based on historical experience and information currently available, the Company believes that it will not be required to make payments under the standby letters of credit or guarantee arrangements for the foreseeable future.

Indemnification Contingencies

There are no new material indemnification contingencies subsequent to the filing of the 2021 Form 10-K.

Legal Matters

The Company is currently involved in a variety of legal matters that arise in the ordinary course of business. Based on information currently available, the Company is not involved in any pending or threatened legal proceedings that it believes could reasonably be expected to have a material adverse effect on its financial condition, results of operations or liquidity. The litigation process is inherently uncertain, and the Company cannot guarantee that the outcome of any litigation matter will be favorable to the Company.

Intellectual Property Matters

The Company faces risk of exposure from claims of infringement of the IP rights of others. In the ordinary course of business, the Company receives letters asserting that the Company’s products or components breach another party’s rights. Such letters may request royalty payments from the Company, that the Company cease and desist using certain IP, and/or request other remedies.

Table of Contents

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Note ~~11:~~12: Fair Value Measurements

Fair Value of Financial Instruments

The Company invests portions of its excess cash in different marketable securities, which are classified as available-for-sale. The following table summarizes the Company's financial assets and liabilities, excluding pension assets, disaggregated by the security type, measured at fair value on a recurring basis (in millions):

~~Table of Contents~~

~~ON SEMICONDUCTOR CORPORATION~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued~~

~~(unaudited)~~


As of April 1, 2022										Fair Value Level
As of September 30, 2022																As of September 30, 2022									Fair Value Level
Description	Description	Amortized Cost		Unrealized gains		Unrealized losses		Fair value		Level 1		Level 2		Level 3		Description	Amortized Cost		Unrealized gains		Unrealized losses		Fair value		Level 1		Level 2		Level 3
Assets:	Assets:															Assets:
Cash and cash equivalents:	Cash and cash equivalents:															Cash and cash equivalents:
Demand and time deposits	Demand and time deposits	$	19.6	$	—	$	—	$	19.6	$	19.6	$	—	$	—	Demand and time deposits	$	168.4	$	—	$	—	$	168.4	$	168.4	$	—	$	—
Money market funds	Money market funds	0.7		—		—		0.7		0.7		—		—		Money market funds	4.0		—		—		4.0		4.0		—		—

Other current assets:	Other current assets:															Other current assets:
Corporate bonds	Corporate bonds	$	22.3	$	—	$	—	$	22.3	$	—	$	22.3	$	—	Corporate bonds	$	23.2	$	—	$	—	$	23.2	$	—	$	23.2	$	—
Certificate of deposit	Certificate of deposit	3.0		—		—		3.0		—		3.0		—		Certificate of deposit	3.4		—		—		3.4		—		3.4		—
Commercial paper	Commercial paper	6.8		—		—		6.8		3.8		3.0		—		Commercial paper	5.4		—		—		5.4		1.5		3.9		—
US Treasury bonds	US Treasury bonds	0.7		—		—		0.7		—		0.7		—		US Treasury bonds	2.1		—		—		2.1		—		2.1		—

Other assets:	Other assets:															Other assets:
Corporate bonds	Corporate bonds	$	14.2	$	—	$	—	$	14.2	$	—	$	14.2	$	—	Corporate bonds	$	3.6	$	—	$	—	$	3.6	$	—	$	3.6	$	—

US Treasury bonds	US Treasury bonds	1.2		—		—		1.2		—		1.2		—		US Treasury bonds	—		—		—		—		—		—		—

The investments included in other assets have maturity dates ranging between one and five years.

Table of Contents

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)


As of December 31, 2021									Fair Value Level
Description	Amortized Cost		Unrealized gains		Unrealized losses		Fair value		Level 1		Level 2		Level 3
Assets:
Cash and cash equivalents:
Demand and time deposits	$	19.5	$	—	$	—	$	19.5	$	19.5	$	—	$	—
Money market funds	0.7		—		—		0.7		0.7		—		—
Corporate bonds	1.6		—		—		1.6		—		1.6		—
Commercial paper	2.0		—		—		2.0		—		2.0		—

Other current assets:
Corporate bonds	$	16.0	$	—	$	—	$	16.0	$	—	$	16.0	$	—
Certificate of deposit	1.9		—		—		1.9		—		1.9		—
Commercial paper	5.0		—		—		5.0		3.0		2.0		—
US Treasury bonds	0.4		—		—		0.4		—		0.4		—

Other assets:
Corporate bonds	$	19.7	$	—	$	—	$	19.7	$	—	$	19.7	$	—

US Treasury bonds	1.6		—		—		1.6		—		1.6		—

~~0Other~~Other

The carrying amounts of other current assets and liabilities, such as accounts receivable and accounts payable, approximate fair value based on the short-term nature of these instruments.

Fair Value of Long-Term Debt, including Current Portion

~~Table of Contents~~

~~ON SEMICONDUCTOR CORPORATION~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued~~

~~(unaudited)~~

The carrying amounts and fair values of the Company’s long-term borrowings were as follows (in millions):


		As of									As of
		April 1, 2022				December 31, 2021					September 30, 2022				December 31, 2021
		Carrying Amount		Fair Value		Carrying Amount		Fair Value			Carrying Amount		Fair Value		Carrying Amount		Fair Value
Long-term debt, including current portion (1)	Long-term debt, including current portion (1)									Long-term debt, including current portion (1)
0% Notes	0% Notes	$	788.7	$	1,077.7	$	664.8	$	1,183.1	0% Notes	$	790.3	$	1,099.8	$	664.8	$	1,183.1
1.625% Notes	1.625% Notes	154.3		474.0		144.6		513.6		1.625% Notes	154.5		466.1		144.6		513.6
Other long-term debt	Other long-term debt	2,262.7		2,137.8		2,265.2		2,245.5		Other long-term debt	2,267.0		2,082.9		2,265.2		2,245.5

(1) Carrying amounts shown are net of debt discount, if applicable, and debt issuance costs.

The fair values of the 3.875% Notes, 1.625% Notes and 0% Notes were estimated based on market prices in active markets (Level 1). The fair value of the Term Loan "B" Facility was estimated based on discounting the remaining principal and interest payments using current market rates for similar debt (Level 2).

Table of Contents

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Note ~~12:~~13: Financial Instruments

Foreign Currencies

As a multinational business, the Company engages in transactions that are denominated in a variety of currencies. When appropriate, the Company uses forward foreign currency contracts to reduce its overall exposure to the effects of currency fluctuations on its results of operations and cash flows. The Company’s policy prohibits trading in currencies for which there are no underlying exposures and entering into trades for any currency to intentionally increase the underlying exposure. The Company primarily hedges existing assets and liabilities associated with transactions currently on its balance sheet, which are undesignated hedges for accounting purposes. The Company is exposed to credit-related losses if counterparties to hedge contracts fail to perform their obligations. As of September 30, 2022, the counterparties to the Company’s hedge contracts were held at financial institutions that the Company believes to be highly-rated, and no credit-related losses are anticipated.

As of ~~April 1,~~September 30, 2022 and December 31, 2021, the Company had net outstanding foreign exchange contracts with notional amounts of ~~$236.7~~$326.2 million and $288.3 million, respectively. Such contracts were obtained through financial institutions and were scheduled to mature within one to three months from the time of purchase. Management believes that these financial instruments should not subject the Company to increased risks from foreign exchange movements because gains and losses on these contracts should offset losses and gains on the underlying assets, liabilities and transactions to which they are related.

The following summarizes the Company’s net foreign exchange positions in U.S. Dollars (in millions):


		As of									As of
		April 1, 2022				December 31, 2021					September 30, 2022				December 31, 2021
		Buy (Sell)		Notional Amount		Buy (Sell)		Notional Amount			Buy (Sell)		Notional Amount		Buy (Sell)		Notional Amount
Japanese Yen										Japanese Yen	66.6		66.6		33.2		33.2
Philippine Peso	Philippine Peso	56.9		56.9		67.1		67.1		Philippine Peso	59.1		59.1		67.1		67.1
Japanese Yen		51.0		51.0		33.2		33.2
Euro										Euro	41.1		41.1		65.9		65.9
Czech Koruna										Czech Koruna	39.1		39.1		15.0		15.0
Korean Won	Korean Won	38.9		38.9		44.1		44.1		Korean Won	35.1		35.1		44.1		44.1
Czech Koruna		24.7		24.7		15.0		15.0
Euro		12.9		12.9		65.9		65.9

Other Currencies - Buy	Other Currencies - Buy	46.6		46.6		58.7		58.7		Other Currencies - Buy	74.7		74.7		58.7		58.7
Other Currencies - Sell	Other Currencies - Sell	(5.7)		5.7		(4.3)		4.3		Other Currencies - Sell	(10.5)		10.5		(4.3)		4.3
		$	225.3	$	236.7	$	279.7	$	288.3		$	305.2	$	326.2	$	279.7	$	288.3

Amounts receivable or payable under the contracts ~~are included in other current assets~~were not material as of September 30, 2022 or ~~accrued expenses and other current liabilities in the accompanying Consolidated Balance Sheets.~~December 31, 2021. During the quarters ended ~~April 1,~~September 30, 2022 and ~~April 2,~~October 1, 2021, realized and unrealized foreign currency transactions totaled a gain of ~~$1.9~~$0.7 million and a loss of $0.8 million, respectively. During the nine months ended September 30, 2022 and October 1, 2021, realized and unrealized foreign currency transactions totaled a gain of ~~$4.0~~$9.0 million and $1.5 million, respectively. The realized and unrealized foreign currency transactions are included in other income (expense) in the Company's Consolidated Statements of Operations and Comprehensive Income.

~~Table of Contents~~

~~ON SEMICONDUCTOR CORPORATION~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued~~

~~(unaudited)~~

Cash Flow Hedges

All derivatives are recognized on the Company’s Consolidated Balance Sheets at their fair value and classified based on the applicable instrument's maturity date.

Foreign Currency Risk

The purpose of the foreign currency hedging activities is to protect the Company from the risk that the eventual cash flows resulting from transactions in foreign currencies will be ~~adversely~~ affected by changes in exchange rates. The Company enters into forward contracts that are designated as a foreign currency cash flow hedge of a forecasted payment denominated in a currency other than U.S. Dollars. For the quarters ended ~~April 1,~~September 30, 2022 and ~~April 2,~~October 1, 2021, the Company did not have outstanding derivatives for its foreign currency exposure designated as cash flow hedges.

Table of Contents

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Interest Rate Risk

The Company uses interest rate swap contracts to mitigate its exposure to interest rate fluctuations. ~~During the quarter ended April 1,~~As of September 30, 2022, the Company had interest rate swap agreements for notional amounts ~~totaling~~of $750.0 ~~million.~~million, $500 million and $500 million for fiscal years 2022, 2023 and 2024, respectively. The fair value of the interest rate swaps totaled $39.1 million as of September 30, 2022, of which approximately $20.2 million was included in other current assets and approximately $18.9 million was included in other non-current assets. The fair value of interest rate swaps totaled $5.7 million as of December 31, 2021, which was included in other non-current assets. The Company did not identify any ineffectiveness with respect to the notional amounts of the interest rate swap contracts ~~outstanding~~effective as of ~~April 1,~~September 30, 2022 and ~~April 2,~~December 31, 2021.

Other

As of ~~April 1,~~September 30, 2022, the Company had no outstanding commodity derivatives, currency swaps, or options, ~~relating to either its debt instruments~~ or ~~investments. The Company does not hedge the value of its~~ equity investments ~~in its~~held at subsidiaries or affiliated companies. The Company is exposed to credit-related losses if counterparties to hedge contracts fail to perform their obligations. As of April 1, 2022, the counterparties to the Company’s hedge contracts were held at financial institutions that the Company believes to be highly-rated, and no credit-related losses are anticipated.

Note ~~13:~~14: Income Taxes

The Company recognizes interest and penalties related to uncertain tax positions in tax expense on the Company's Consolidated Statements of Operations and Comprehensive Income. The Company had approximately ~~$1.5~~$1.9 million and ~~$3.0~~$1.3 million of net interest and penalties accrued as of ~~April 1,~~September 30, 2022 and ~~April 2,~~December 31, 2021, respectively. It is reasonably possible that ~~$64.2~~$62.5 million of its uncertain tax positions will be reduced in the next 12 months due to settlement with tax authorities or expiration of the applicable statute of limitations.

The Company maintains a partial valuation allowance on its U.S. state deferred tax assets and a valuation allowance on foreign net operating losses and tax credits in certain foreign jurisdictions, a substantial portion of which relate to Japan and Hong Kong net operating losses, which are projected to expire prior to utilization.

The Company is currently under IRS examination for the 2017 and 2018 tax ~~year.~~years. Tax years prior to 2017 are generally not subject to examination by the IRS. For state tax returns, the Company is generally not subject to income tax examinations for tax years prior to 2017. The Company is also subject to routine examinations by various foreign tax jurisdictions in which it operates. With respect to jurisdictions outside the United States, the Company is generally not subject to examination for tax years prior to ~~2011.~~2012. The Company believes that adequate provisions have been made for any adjustments that may result from tax examinations. However, the outcome of tax audits cannot be predicted with certainty. If any issues addressed in the Company’s tax audits are resolved in a manner not consistent with the Company's expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs.

~~Table of Contents~~

~~ON SEMICONDUCTOR CORPORATION~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued~~

~~(unaudited)~~

Note ~~14:~~15: Changes in Accumulated Other Comprehensive Loss

Amounts comprising the Company's accumulated other comprehensive loss and reclassifications are as follows (in millions):


		Currency Translation Adjustments		Effects of Cash Flow Hedges and Other Adjustments		Total			Currency Translation Adjustments		Effects of Cash Flow Hedges and Other Adjustments		Total
Balance as of December 31, 2021	Balance as of December 31, 2021	$	(44.4)	$	3.8	$	(40.6)	Balance as of December 31, 2021	$	(44.4)	$	3.8	$	(40.6)
Other comprehensive income (loss) prior to reclassifications	Other comprehensive income (loss) prior to reclassifications	(2.4)		17.3		14.9		Other comprehensive income (loss) prior to reclassifications	(8.4)		22.6		14.2
Amounts reclassified from accumulated other comprehensive loss	Amounts reclassified from accumulated other comprehensive loss	—		(0.7)		(0.7)		Amounts reclassified from accumulated other comprehensive loss	—		3.0		3.0
Net current period other comprehensive income (loss) (1)	Net current period other comprehensive income (loss) (1)	(2.4)		16.6		14.2		Net current period other comprehensive income (loss) (1)	(8.4)		25.6		17.2
Balance as of April 1, 2022		$	(46.8)	$	20.4	$	(26.4)
Balance as of September 30, 2022								Balance as of September 30, 2022	$	(52.8)	$	29.4	$	(23.4)

(1) Effects of cash flow hedges are net of tax expense of ~~$5.1~~$7.8 million for the ~~quarter~~nine months ended ~~April 1,~~September 30, 2022.

Table of Contents

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Amounts reclassified from accumulated other comprehensive loss to the specific caption within Consolidated Statements of Operations and Comprehensive Income were as follows:


		Quarters Ended					Quarters Ended				Nine Months Ended
		April 1, 2022		April 2, 2021		To caption			September 30, 2022		October 1, 2021		September 30, 2022		October 1, 2021		To caption

Interest rate swaps	Interest rate swaps	$	0.7	$	4.6	Interest expense		Interest rate swaps	$	(3.2)	$	4.9	$	(3.0)	$	14.3	Interest expense
Total reclassifications	Total reclassifications	$	0.7	$	4.6			Total reclassifications	$	(3.2)	$	4.9	$	(3.0)	$	14.3

2328

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion in conjunction with our audited historical consolidated financial statements, which are included in the 2021 Form 10-K and our unaudited consolidated financial statements for the fiscal quarter ended ~~April 1,~~September 30, 2022, which are included elsewhere in this Form 10-Q. This Management's Discussion and Analysis of Financial Condition and Results of Operations contains statements that are forward-looking. These statements are based on current expectations and assumptions that are subject to risks, uncertainties and other factors. Actual results could differ materially because of the factors discussed below or elsewhere in this Form 10-Q. See Part II, Item 1A. "Risk Factors" of this Form 10-Q and Part I, Item 1A. "Risk Factors" of the 2021 Form 10-K.

Executive Overview

onsemi Overview

We provide ~~industry leading~~industry-leading intelligent power and sensing solutions to help our customers solve the most challenging problems and create cutting edge products for a better future. Our intelligent power technologies enable the electrification of the automotive industry that allows for lighter and longer-range electric vehicles, empowers efficient fast-charging systems and propels sustainable energy for the highest efficiency solar strings, industrial power and storage systems. Our intelligent sensing technologies support the next-generation industry, allowing for smarter factories and buildings while also enhancing the automotive mobility experience with imaging and depth sensing that make advanced vehicle safety and automated driving systems possible.

onsemi’s intelligent power allows our customers to exceed range targets with lower weight and reduce system ~~cost~~costs through efficiency. With our sensing integration, we believe onsemi’s intelligent power solutions achieve higher efficiencies compared to our peers and allow lower temperature operation, reducing cooling requirements, saving costs and minimizing weight while delivering the required power with less die per module and achieving higher range for a given battery capacity. onsemi’s intelligent sensing solutions offer proprietary features in smaller packages that support customers' use cases. We believe our intelligent sensing technology offers advanced features to achieve optimal results and our product integration drives improved efficiency. This performance is delivered in a smaller footprint while reducing system latency to increase safety and throughput by providing a proprietary feature set to solve different use cases.

We serve a broad base of end-user markets, including automotive, industrial and others, which include communications, computing and consumer. We believe the evolution of automotive, with advancements in autonomous driving, ADAS, vehicle electrification and the increase in electronics content for vehicle platforms, is reshaping the boundaries of transportation. With our extensive portfolio of AEC-qualified products, onsemi helps customers design ~~high reliability~~high-reliability solutions while delivering top performance. Within the industrial space, onsemi is helping OEMs develop innovative products to navigate the ongoing transformation across energy infrastructure, factory automation and power conversion.

As of ~~April 1,~~September 30, 2022, we were organized into the three operating and reportable segments of PSG, ASG and ISG.

Business Strategy Developments

Our primary focus continues to be on gross margin and operating margin expansion, while at the same time achieving revenue growth in our focused end-markets of automotive ~~industrial~~ and ~~communications~~industrial infrastructure, as well as ~~being opportunistic~~focusing on profitable growth opportunities in other end-markets, including obtaining longer-term supply arrangements with strategic end-customers. We are also focused on achieving efficiencies in our operating expenditures. ~~While we~~We believe we have made significant progress on gross margin and operating margin expansion ~~we continue to rationalize~~by focusing our ~~product portfolio and have allocated~~ capital allocation on research and development investments and resources to accelerate growth in high-margin products and ~~end-markets~~end-markets. Additionally, we continue to rationalize our product portfolio by moving away from non-differentiated products, which have had historically lower gross margins.

During the first ~~quarter,~~nine months of 2022, we divested our ~~six-inch~~ front-end wafer manufacturing facilities in Oudenaarde, Belgium and South Portland, Maine, and our non-strategic GTAT Sapphire business in Salem, Massachusetts. We have signed wafer supply agreements with the buyers of the Belgium and South Portland, Maine manufacturing facilities to ensure that there is no disruption in our ability to meet customer demand for our products. Additionally, during the first nine months of 2022, we completed the sale of two office buildings and the sale of our Corporate Headquarters facilities in Phoenix, Arizona.

In September 2022, we approved an exit plan to wind down our QCS division within the Advanced Solutions Group segment, which will further enable us to direct our investments to areas of strategic focus, which include intelligent power and intelligent sensing, streamline our operations and improve costs.

Table of Contents

During the third quarter of 2022, we entered into a Stock Purchase Agreement with JS Foundry K.K., to divest our wafer manufacturing facility in ~~Oudenaarde, Belgium and entered into a definitive agreement to sell our eight-inch front-end wafer manufacturing facility in South Portland, Maine, which~~Niigata, Japan. The transaction is expected to close ~~during~~as soon as regulatory approvals are received and closing conditions are met.

Subsequent to quarter end, on October 14, 2022, we completed the ~~second quarter~~divestiture of ~~2022. We are also exploring the sale of certain other~~our manufacturing ~~facilities.~~facility in Pocatello, Idaho. We believe these actions, among others, will allow us to transition to a lighter internal fabrication model where our financial performance will be less volatile and not as heavily influenced by our internal manufacturing volumes. As actions are initiated to achieve our business strategy goals, we could incur accounting charges in the future.

~~We are focused~~As part of our ongoing strategy, we continue to focus on ~~sustainability as we drive a common theme across all markets.~~sustainability. During 2021, ~~onsemi~~we announced ~~its~~our commitment to achieving net zero emissions by 2040. As we initiate steps to achieve our sustainability goals, additional

~~Table of Contents~~

investments may be required in the future in connection with such actions, although the timing and amounts of such investments are uncertain at this time.

Impact of the Novel Coronavirus Disease 2019 (“COVID-19”) Pandemic on our Business

We have implemented proactive preventative protocols and updated our business practices in response to the ongoing COVID-19 pandemic. These changes are intended to safeguard our employees, contractors, suppliers and communities. While all of our global manufacturing sites and most of our distribution centers are currently operational, the ongoing COVID-19 pandemic and its effects are impacting and will likely continue to impact market conditions and operations worldwide, including the operations of our Company, and government mandates may order us to curtail production levels or temporarily suspend manufacturing or distribution operations in response to further outbreaks or new COVID-19 variants.

New Legislation

In August of 2022, the CHIPS Act and the IRA were signed into law. Among other things, the CHIPS Act of 2022 provides various incentives and tax credits to U.S. companies for research, development, manufacturing and workforce development. The IRA introduces a 15% CAMT for certain corporations. See Note 3: ''Recent Accounting Pronouncements and Other Developments'' in the notes to our unaudited consolidated financial statements included elsewhere in this Form 10-Q for additional information.

2530

Table of Contents

Results of Operations

Quarter Ended ~~April 1,~~September 30, 2022 compared to the Quarter Ended ~~April 2,~~October 1, 2021

The following table summarizes certain information relating to our operating results that has been derived from our unaudited consolidated financial statements (in millions):


		Quarters Ended							Quarters Ended
		April 1, 2022		April 2, 2021		Dollar Change			September 30, 2022		October 1, 2021		Dollar Change
Revenue	Revenue	$	1,945.0	$	1,481.7	$	463.3	Revenue	$	2,192.6	$	1,742.1	$	450.5
Cost of revenue (exclusive of amortization shown below)	Cost of revenue (exclusive of amortization shown below)	983.7		960.5		23.2		Cost of revenue (exclusive of amortization shown below)	1,134.3		1,021.3		113.0
Gross profit	Gross profit	961.3		521.2		440.1		Gross profit	1,058.3		720.8		337.5
Operating expenses:	Operating expenses:							Operating expenses:
Research and development	Research and development	156.8		173.6		(16.8)		Research and development	145.4		154.5		(9.1)
Selling and marketing	Selling and marketing	71.1		78.9		(7.8)		Selling and marketing	69.5		68.4		1.1
General and administrative	General and administrative	77.9		72.4		5.5		General and administrative	84.9		75.7		9.2

Amortization of acquisition-related intangible assets	Amortization of acquisition-related intangible assets	21.3		25.0		(3.7)		Amortization of acquisition-related intangible assets	21.9		24.7		(2.8)
Restructuring, asset impairments and other charges, net		(13.0)		42.5		(55.5)
Intangible asset impairment		—		2.9		(2.9)
Restructuring, asset impairments and other, net								Restructuring, asset impairments and other, net	40.3		(1.7)		42.0
Goodwill and intangible asset impairment								Goodwill and intangible asset impairment	271.8		—		271.8
Total operating expenses	Total operating expenses	314.1		395.3		(81.2)		Total operating expenses	633.8		321.6		312.2
Operating income	Operating income	647.2		125.9		521.3		Operating income	424.5		399.2		25.3
Other income (expense), net:	Other income (expense), net:							Other income (expense), net:
Interest expense	Interest expense	(21.6)		(33.4)		11.8		Interest expense	(23.7)		(31.9)		8.2
Interest income	Interest income	0.4		0.4		—		Interest income	4.9		0.5		4.4

Gain on divestiture of business								Gain on divestiture of business	0.2		10.2		(10.0)

Other income (expense)	Other income (expense)	2.1		4.5		(2.4)		Other income (expense)	0.9		(5.8)		6.7
Other income (expense), net	Other income (expense), net	(19.1)		(28.5)		9.4		Other income (expense), net	(17.7)		(27.0)		9.3
Income before income taxes	Income before income taxes	628.1		97.4		530.7		Income before income taxes	406.8		372.2		34.6
Income tax provision	Income tax provision	(97.1)		(7.1)		(90.0)		Income tax provision	(94.9)		(61.8)		(33.1)
Net income	Net income	531.0		90.3		440.7		Net income	311.9		310.4		1.5
Less: Net income attributable to non-controlling interest	Less: Net income attributable to non-controlling interest	(0.8)		(0.4)		(0.4)		Less: Net income attributable to non-controlling interest	—		(0.7)		0.7
Net income attributable to ON Semiconductor Corporation	Net income attributable to ON Semiconductor Corporation	$	530.2	$	89.9	$	440.3	Net income attributable to ON Semiconductor Corporation	$	311.9	$	309.7	$	2.2

Revenue

Revenue was ~~$1,945.0~~$2,192.6 million and ~~$1,481.7~~$1,742.1 million for the quarters ended ~~April 1,~~September 30, 2022 and ~~April 2,~~October 1, 2021, respectively, representing an increase of ~~$463.3~~$450.5 million, or approximately ~~31%~~26%. We had one customer, a distributor, whose revenue accounted for approximately ~~12.4%~~12% and ~~10.6%~~14% of our total revenue for the quarters ended ~~April 1,~~September 30, 2022 and ~~April 2,~~October 1, 2021, respectively.

Revenue by operating and reportable segments was as follows (dollars in millions):


		Quarter Ended April 1, 2022		As a % of Total Revenue (1)		Quarter Ended April 2, 2021		As a % of Total Revenue (1)			Quarter Ended September 30, 2022		As a % of Total Revenue (1)		Quarter Ended October 1, 2021		As a % of Total Revenue (1)
PSG	PSG	$	986.7	50.7	%	$	747.0	50.4	%	PSG	$	1,116.1	50.9	%	$	892.1	51.2	%
ASG	ASG	689.3		35.4	%	531.5		35.9	%	ASG	734.3		33.5	%	613.5		35.2	%
ISG	ISG	269.0		13.8	%	203.2		13.7	%	ISG	342.2		15.6	%	236.5		13.6	%
Total revenue	Total revenue	$	1,945.0			$	1,481.7			Total revenue	$	2,192.6			$	1,742.1

(1) Certain amounts may not total due to rounding of individual amounts.

Table of Contents

Revenue from PSG increased by ~~$239.7~~$224.0 million, or approximately ~~32%~~25%, for the quarter ended ~~April 1,~~September 30, 2022 compared to the quarter ended ~~April 2,~~October 1, 2021. The revenue from our Advanced Power Division and our Integrated Circuits, Protection and Signal Division increased by ~~$170.6~~$200.4 million and ~~$69.1~~$23.5 million, respectively, primarily due to our strategy to focus on a product mix

~~Table of Contents~~

that yields higher margins and an increase in average selling prices driven by ~~improving economic conditions,~~strong market demand, compared to the quarter ended ~~April 2,~~October 1, 2021.

Revenue from ASG increased by ~~$157.8~~$120.8 million, or approximately ~~30%~~20%, for the quarter ended ~~April 1,~~September 30, 2022 compared to the quarter ended ~~April 2,~~October 1, 2021. The revenue from our Automotive Division, Industrial Solutions Division, and Mobile, Computing and Cloud Division increased by ~~$55.2~~$54.1 million, $53.4 million and ~~$43.2~~$19.9 million, respectively. The increases were primarily due to our strategy to focus on a product mix that yields higher margins, and an increase in average selling prices driven by strong market demand, compared to the quarter ended ~~April 2,~~October 1, 2021.

Revenue from ISG increased by ~~$65.8~~$105.7 million, or approximately ~~32%~~45%, for the quarter ended ~~April 1,~~September 30, 2022 compared to the quarter ended ~~April 2,~~October 1, 2021, largely driven by an increase in revenue from our Automotive Sensing Division of ~~$62.2~~$99.3 million. The increase was due to our strategy to focus on a product mix that yields higher margins, ~~better demand~~ and an increase in average selling ~~prices.~~prices driven by strong market demand, compared to the quarter ended October 1, 2021.

Revenue by geographic location, based on sales billed from the respective country or region, was as follows (dollars in millions):


		Quarter Ended April 1, 2022		As a % of Total Revenue (1)		Quarter Ended April 2, 2021		As a % of Total Revenue (1)			Quarter Ended September 30, 2022		As a % of Total Revenue (1)		Quarter Ended October 1, 2021		As a % of Total Revenue (1)
Singapore	Singapore	$	555.7	28.6	%	$	509.0	34.4	%	Singapore	$	544.0	24.8	%	$	544.0	31.2	%
Hong Kong	Hong Kong	529.6		27.2	%	342.2		23.1	%	Hong Kong	617.9		28.2	%	487.0		28.0	%
United Kingdom	United Kingdom	345.5		17.8	%	268.9		18.1	%	United Kingdom	372.5		17.0	%	273.2		15.7	%
United States	United States	311.7		16.0	%	184.3		12.4	%	United States	415.4		18.9	%	238.7		13.7	%
Other	Other	202.5		10.4	%	177.3		12.0	%	Other	242.8		11.1	%	199.2		11.4	%
Total revenue	Total revenue	$	1,945.0			$	1,481.7			Total revenue	$	2,192.6			$	1,742.1

(1) Certain amounts may not total due to rounding of individual amounts.

Gross Profit and Gross Margin (exclusive of amortization of acquisition-related intangible assets)

Our gross profit by operating and reportable segments was as follows (dollars in millions):


		Quarter Ended April 1, 2022				As a % of Segment Revenue (1)			Quarter Ended April 2, 2021				As a % of Segment Revenue (1)				Quarter Ended September 30, 2022				As a % of Segment Revenue (1)			Quarter Ended October 1, 2021				As a % of Segment Revenue (1)

PSG	PSG			$	474.7		48.1	%			$	246.5		33.0		%	PSG		$	508.5		45.6	%			$	346.0		38.8	%
ASG	ASG	366.7				53.2	%		206.8				38.9	%	ASG		381.7				52.0	%		280.1				45.7	%
ISG	ISG	119.9				44.6	%		67.9				33.4	%	ISG		168.1				49.1	%		94.7				40.0	%
Total gross profit	Total gross profit	$	961.3			49.4	%		$	521.2			35.2	%	Total gross profit		$	1,058.3			48.3	%		$	720.8			41.4	%

(1)Certain amounts may not total due to rounding of individual amounts.

Our gross profit increased by ~~$440.1~~$337.5 million, or approximately ~~84%~~47%, from ~~$521.2~~$720.8 million for the quarter ended ~~April 2,~~October 1, 2021 to ~~$961.3~~$1,058.3 million for the quarter ended ~~April 1,~~September 30, 2022. Our ~~overall~~ gross margin increased to ~~49.4%~~48.3% for the quarter ended ~~April 1,~~September 30, 2022 from ~~approximately 35.2%~~41.4% for the quarter ended ~~April 2,~~October 1, 2021.

The significant ~~increases~~increase in both gross profit and gross margin ~~were due to an increase in average selling prices and a favorable product mix with~~was primarily driven by higher ~~gross margins and improved manufacturing efficiencies. The favorable economic environment and significant improvement in demand in all end-markets, specifically~~revenue, particularly in the automotive and industrial end-markets, ~~contributed~~and a favorable product mix, which included actions aimed to ~~increased demand and better pricing~~resolve price-to-value discrepancies for our products. ~~We were also able to pass most of the increases in input cost of raw materials and external manufacturing services to our customers.~~

~~Operating Expenses~~

Research and development expenses were $156.8 million for the quarter ended April 1, 2022, as compared to $173.6 million for the quarter ended April 2, 2021, representing a decrease of $16.8 million, or approximately 10%. The decrease was primarily due to a decrease in payroll-related expenses as a result of the restructuring programs implemented during 2021.

2732

Table of Contents

~~Selling~~Operating Expenses

Research and ~~marketing~~development expenses were ~~$71.1~~$145.4 million for the quarter ended ~~April 1,~~September 30, 2022, as compared to ~~$78.9~~$154.5 million for the quarter ended ~~April 2,~~October 1, 2021, representing a decrease of ~~$7.8~~$9.1 million, or approximately ~~10%~~6%. The decrease was primarily due to a ~~decrease~~reduction in ~~payroll-related~~payroll and other expenses as a result of the restructuring programs implemented during ~~2021.~~the period.

Selling and marketing expenses were $69.5 million for the quarter ended September 30, 2022, as compared to $68.4 million for the quarter ended October 1, 2021, representing an increase of $1.1 million, or approximately 2%. The increase was primarily due to an increase in variable compensation and travel-related expenses, partially offset by a decrease in payroll-related expenses.

General and administrative expenses were ~~$77.9~~$84.9 million for the quarter ended ~~April 1,~~September 30, 2022, as compared to ~~$72.4~~$75.7 million for the quarter ended ~~April 2,~~October 1, 2021, representing an increase of ~~$5.5~~$9.2 million, or approximately 8%12%. The increase was primarily due to higher stock compensation, variable compensation and payroll-related expenses.

Other Operating Expenses

Amortization of Acquisition-Related Intangible Assets

Amortization of acquisition-related intangible assets was ~~$21.3~~$21.9 million for the quarter ended ~~April 1,~~September 30, 2022, as compared to ~~$25.0~~$24.7 million for the quarter ended ~~April 2,~~October 1, 2021, representing a decrease of ~~$3.7~~$2.8 million, or approximately ~~15%~~11%. The decrease in expense was due to the reduction in amortization expense as certain intangible technology-related assets became fully amortized in 2021.

Restructuring, Asset Impairments and Other, Net

Restructuring, asset impairments and other, net was $40.3 million for the quarter ended September 30, 2022, as compared to a credit of $1.7 million for the quarter ended October 1, 2021. During the quarter ended September 30, 2022, we approved an exit plan to wind down the legacy QCS division as part of our ongoing efforts to focus on growth drivers and key markets and to streamline our operations. Charges during the third quarter of 2022, represent severance charges, contract termination costs and litigation expenses. Amounts incurred for the quarter ended October 1, 2021 primarily relate to the 2021 involuntary severance plan. See Note 6: ''Restructuring, Asset Impairments and Other, Net'' in the notes to our unaudited consolidated financial statements included elsewhere in this Form 10-Q for additional information.

Goodwill and Intangible Asset Impairment

Goodwill and intangible asset impairment was $271.8 million for the quarter ended September 30, 2022, as compared to zero for the quarter ended October 1, 2021. During the quarter ended September 30, 2022, we approved an exit plan to wind down the QCS division and impaired the remaining goodwill and unamortized intangible assets impairment charges of $215.0 million and $56.8 million, respectively. See Note 5: ''Goodwill and Intangible Assets'' in the notes to our unaudited consolidated financial statements included elsewhere in this Form 10-Q for additional information.

Interest Expense

Interest expense decreased by $8.2 million to $23.7 million during the quarter ended September 30, 2022, as compared to $31.9 million during the quarter ended October 1, 2021. The decrease was primarily due to ~~full~~a lack of amortization of ~~certain~~debt discount on our convertible notes due to the adoption of ASU 2020-06, lower interest rates as a result of interest rate swap contracts and a decrease in our long-term debt. Our average gross long-term debt balance (including current maturities) for the quarter ended September 30, 2022 was $3,250.1 million at a weighted-average interest rate of 2.9%, as compared to $3,311.9 million at a weighted-average interest rate of 3.9% for the quarter ended October 1, 2021. The calculation of our weighted-average interest rates includes the effect of our interest rate swap agreements.

Other Income (Expense)

Other income (expense) was an income of $0.9 million during the quarter ended September 30, 2022 compared to an expense of $5.8 million during the quarter ended October 1, 2021. The increase was primarily due to the fluctuations in foreign currencies resulting in increased transaction gains offset by losses on hedges that were realized.

Table of Contents

Income Tax Provision

We recorded an income tax provision of $94.9 million and $61.8 million for the quarters ended September 30, 2022 and October 1, 2021, respectively, representing effective tax rates of 23.3% and 16.6%. The increase in our effective tax rate was substantially driven by the impact of goodwill impairments, which are not deductible for tax purposes.

For additional information, see Note 14: ''Income Taxes'' and Note 7: ''Balance Sheet Information and Other'' in the notes to the unaudited consolidated financial statements included elsewhere in this Form 10-Q.

Results of Operations

Nine Months EndedSeptember 30, 2022 compared to the Nine Months Ended October 1, 2021

The following table summarizes certain information relating to our operating results that has been derived from our unaudited consolidated financial statements (in millions):


	Nine Months Ended
	September 30, 2022		October 1, 2021		Dollar Change
Revenue	$	6,222.6	$	4,893.7	$	1,328.9
Cost of revenue (exclusive of amortization shown below)	3,165.9		3,011.6		154.3
Gross profit	3,056.7		1,882.1		1,174.6
Operating expenses:
Research and development	463.8		494.4		(30.6)
Selling and marketing	213.7		223.4		(9.7)
General and administrative	246.0		221.3		24.7

Amortization of acquisition-related intangible assets	65.1		74.5		(9.4)
Restructuring, asset impairments and other, net	25.6		58.3		(32.7)
Goodwill and intangible asset impairment	386.8		2.9		383.9
Total operating expenses	1,401.0		1,074.8		326.2
Operating income	1,655.7		807.3		848.4
Other income (expense), net:
Interest expense	(67.4)		(98.4)		31.0
Interest income	6.4		1.1		5.3
Loss on debt refinancing and prepayment	(7.3)		(26.2)		18.9

Gain on divestiture of business	2.1		10.2		(8.1)

Other income (expense)	9.4		(2.4)		11.8
Other income (expense), net	(56.8)		(115.7)		58.9
Income before income taxes	1,598.9		691.6		907.3
Income tax provision	(299.4)		(106.8)		(192.6)
Net income	1,299.5		584.8		714.7
Less: Net income attributable to non-controlling interest	(1.6)		(1.1)		(0.5)
Net income attributable to ON Semiconductor Corporation	$	1,297.9	$	583.7	$	714.2

Table of Contents

Revenue

Revenue was $6,222.6 million and $4,893.7 million for the nine months ended September 30, 2022 and nine months ended October 1, 2021, respectively, representing an increase of $1,328.9 million, or approximately 27%. We had one customer, a distributor, whose revenue accounted for approximately 12% of our total revenue for the nine months ended September 30, 2022 and 13% of our total revenue for the nine months ended October 1, 2021.

Revenue by operating and reportable segments was as follows (dollars in millions):


	Nine Months Ended September 30, 2022		As a % of Total Revenue (1)		Nine Months Ended October 1, 2021		As a % of Total Revenue (1)
PSG	$	3,159.8	50.8	%	$	2,485.7	50.8	%
ASG	2,140.3		34.4	%	1,752.6		35.8	%
ISG	922.5		14.8	%	655.4		13.4	%
Total revenue	$	6,222.6			$	4,893.7

(1) Certain amounts may not total due to rounding of individual amounts.

Revenue from PSG increased by $674.1 million, or approximately 27%, for the nine months ended September 30, 2022 compared to the nine months ended October 1, 2021. The revenue from our Advanced Power Division and our Integrated Circuits, Protection and Signal Division increased by $537.8 million and $136.2 million, respectively, primarily due to our strategy to focus on a product mix that yields higher margins, and an increase in average selling prices driven by strong market demand, compared to the nine months ended October 1, 2021.

Revenue from ASG increased by $387.7 million, or approximately 22%, for the nine months ended September 30, 2022 compared to the nine months ended October 1, 2021. The revenue from our Automotive Division, Industrial Solutions Division and Mobile, Computing and Cloud Division increased by $150.5 million, $141.7 million and $102.7 million, respectively. The increases were primarily due to our strategy to focus on a product mix that yields higher margins and an increase in average selling prices driven by strong market demand, compared to the nine months ended October 1, 2021.

Revenue from ISG increased by $267.1 million, or approximately 41%, for the nine months ended September 30, 2022 compared to the nine months ended October 1, 2021. The increase was largely due to an increase in revenue from our Automotive Sensing Division of $261 million. The increase was primarily due to our strategy to focus on a product mix that yields higher margins, and an increase in average selling prices driven by strong market demand, compared to the nine months ended October 1, 2021.

Revenue by geographic location, including local sales made by operations within each area, based on sales billed from the respective region, was as follows (dollars in millions):


	Nine Months Ended September 30, 2022		As a % of Total Revenue (1)		Nine Months Ended October 1, 2021		As a % of Total Revenue (1)
Singapore	$	1,655.5	26.6	%	$	1,586.0	32.4	%
Hong Kong	1,731.9		27.8	%	1,278.5		26.1	%
United Kingdom	1,077.7		17.3	%	818.6		16.7	%
United States	1,088.3		17.5	%	648.6		13.3	%
Other	669.2		10.8	%	562.0		11.5	%
Total revenue	$	6,222.6			$	4,893.7

(1) Certain amounts may not total due to rounding of individual amounts.

Table of Contents

Gross Profit and Gross Margin (exclusive of amortization of acquisition-related intangible assets described below)

Our gross profit by operating and reportable segments was as follows (dollars in millions):


	Nine Months Ended September 30, 2022		As a % of Segment Revenue (1)		Nine Months Ended October 1, 2021		As a % of Segment Revenue (1)

PSG	$	1,494.4	47.3	%	$	906.8	36.5	%
ASG	1,128.7		52.7	%	739.2		42.2	%
ISG	433.6		47.0	%	236.1		36.0	%
Total gross profit	$	3,056.7	49.1	%	$	1,882.1	38.5	%

(1)Certain amounts may not total due to rounding of individual amounts.

(2)Beginning in the first quarter of 2021, unallocated manufacturing costs were included as part of segment operating results to determine segment gross profit. As a result, the prior-period amounts have been reclassified to conform to current-period presentation.

Our gross profit was $3,056.7 million for the nine months ended September 30, 2022 compared to $1,882.1 million for the nine months ended October 1, 2021. Gross profit increased by $1,174.6 million, or approximately 62%. Gross margin increased to 49.1% for the nine months ended September 30, 2022 from 38.5% for the nine months ended October 1, 2021.

The significant increase in both gross profit and gross margin was primarily driven by higher revenue, particularly in the automotive and industrial end-markets, and a favorable product mix, which included actions aimed to resolve price-to-value discrepancies for our products.

Operating Expenses

Research and development expenses were $463.8 million for the nine months ended September 30, 2022, as compared to $494.4 million for the nine months ended October 1, 2021, representing a decrease of $30.6 million, or approximately 6%. The decrease was primarily due to a decrease in payroll-related expenses.

Selling and marketing expenses were $213.7 million for the nine months ended September 30, 2022, as compared to $223.4 million for the nine months ended October 1, 2021, representing a decrease of $9.7 million, or approximately 4%. The decrease was primarily due to a reduction in payroll-related expenses.

General and administrative expenses were $246.0 million for the nine months ended September 30, 2022, as compared to $221.3 million for the nine months ended October 1, 2021, representing an increase of $24.7 million, or approximately 11%. The increase was primarily due to higher variable compensation and stock compensation.

Other Operating Expenses

Amortization of Acquisition-Related Intangible Assets

Amortization of acquisition-related intangible assets was $65.1 million and $74.5 million for the nine months ended September 30, 2022 and nine months ended October 1, 2021, respectively, representing a decrease of $9.4 million, or approximately 13%. The decrease in expense was due to the reduction in amortization expense as certain intangible technology-related assets ~~from our previous acquisitions during~~became fully amortized in 2021.

Restructuring, Asset Impairments and Other, Net

Restructuring, asset impairments and other, net was ~~a credit of $13.0~~$25.6 million for the ~~quarter~~nine months ended ~~April 1,~~September 30, 2022, as compared to ~~$42.5~~$58.3 million for the ~~quarter~~nine months ended ~~April 2, 2021. There were no new restructuring programs implemented during the quarter ended April~~October 1, ~~2022. The credit includes~~2021, representing a ~~gain from the sale~~decrease of ~~an office building.~~$32.7 million. Charges represent severance charges, contract termination costs and litigation expenses. Amounts incurred for the ~~quarter~~nine months ended ~~April 2,~~October 1, 2021 primarily relate to the 2021 involuntary severance plan. For additional information, ~~See~~see Note 5:6: ''Restructuring, Asset Impairments and Other, Net'' in the notes to our unaudited consolidated financial statements included elsewhere in this Form 10-Q.

Table of Contents

Goodwill and Intangible Asset Impairment

Goodwill and intangible asset impairment was $386.8 million for the nine months ended September 30, 2022, as compared to $2.9 million for the nine months ended October 1, 2021. During the second quarter of 2022, the Company recorded a goodwill impairment charge of $115.0 million, as a result of a shift in our focus on long-term product mix in our strategic markets. During the third quarter of 2022, we approved an exit plan to wind down the QCS division and recorded goodwill and intangible asset impairment charges of $215.0 million and $56.8 million, respectively. See Note 5: ''Goodwill and Intangible Assets'' in the notes to our unaudited consolidated financial statements included elsewhere in this Form 10-Q for additional information.

Interest Expense

Interest expense decreased by ~~$11.8~~$31.0 million to ~~$21.6~~$67.4 million during the ~~quarter~~nine months ended ~~April 1,~~September 30, 2022, as compared to ~~$33.4~~$98.4 million during the ~~quarter~~nine months ended ~~April 2,~~October 1, 2021. The decrease was primarily due to ~~a decrease in our long-term debt, repayment of interest bearing debt using the proceeds from 0% Notes and~~ the lack of amortization of debt discount on our convertible notes due to the adoption of ASU ~~2020-06.~~2020-06, lower interest rates as a result of interest rate swap contracts, and a decrease in our long-term debt. Our average gross long-term debt balance (including current maturities) for the ~~quarter~~nine months ended ~~April 1,~~September 30, 2022 was ~~$3,256.3~~$3,253.5 million at a weighted-average interest rate of ~~2.7%~~2.8%, as compared to ~~$3,512.5~~$3,449.7 million at a weighted-average interest rate of 3.8% for the ~~quarter~~nine months ended ~~April 2,~~October 1, 2021. The calculation of our weighted-average interest rates includes the effect of our interest rate swap agreements.

Loss on Debt Refinancing and Prepayment

Loss on debt refinancing and prepayment was $7.3 million for the nine months ended September 30, 2022, as compared to $26.2 million for the nine months ended October 1, 2021. The loss on debt refinancing and prepayment for the nine months ended October 1, 2021 primarily related to the partial prepayment of the Term Loan "B" Facility.

Gain on Divestiture of Business

Gain on divestiture of a business was $2.1 million during the nine months ended September 30, 2022, as compared to $10.2 for the nine months ended October 1, 2021. The gain relates to the divestiture of the wafer manufacturing facility in South Portland, Maine and the sale of the non-strategic GTAT Sapphire business in Salem, Massachusetts. See Note 4: ''Acquisition and Divestitures'' in the notes to our unaudited consolidated financial statements included elsewhere in this Form 10-Q for additional information.

Other Income (Expense)

Other income (expense) ~~decreased by~~was income of $9.4 million for the nine months ended September 30, 2022 as compared to income of $2.4 million ~~from an income of $4.5 million during~~for the ~~quarter~~nine months ended ~~April 2, 2021~~October 1, 2021. The increase was primarily due to ~~an income of $2.1 million during~~ the ~~quarter ended April 1, 2022.~~fluctuations in foreign currencies resulting in increased transaction gains offset by losses on hedges that were realized.

Income Tax Provision

We recorded an income tax provision of ~~$97.1~~$299.4 million and ~~$7.1~~$106.8 million ~~for~~during the ~~quarters~~nine months ended ~~April 1,~~September 30, 2022 and ~~April 2,~~October 1, 2021, respectively, representing effective tax rates of ~~15.5%~~18.7% and ~~7.3%~~15.4%. The increase in our effective tax rate was substantially driven by the impact of ~~discrete~~goodwill impairments, which are not deductible for tax ~~benefits in the prior year, relative to prior year pre-tax income. The prior year discrete benefits primarily related to releases in uncertain tax positions and net equity award windfalls.~~purposes.

For additional information, see Note ~~13:~~14: ''Income Taxes'' and Note 7: ''Balance Sheet Information and Other'' in the notes to the unaudited consolidated financial statements included elsewhere in this Form 10-Q.

Liquidity and Capital Resources

~~This section includes a discussion and analysis of our cash requirements, contingencies, sources and uses of cash, operations, working capital and long-term assets and liabilities.~~

~~Contingencies~~

We are a party to a variety of agreements entered into in the ordinary course of business pursuant to which we may be obligated to indemnify other parties for certain liabilities that arise out of or relate to the subject matter of the agreements. Some of the agreements entered into by us require us to indemnify the other party against losses, including but not limited to, losses due to

2837

Table of Contents

IP infringement, environmental contamination and other property damage, personal injury, our failure to comply with applicable laws, our negligence or willful misconduct or our breach of representations, warranties or covenants related to such matters as title to sold assets.

We face risk of exposure to warranty and product liability claims in the event that our products fail to perform as expected or such failure of our products results, or is alleged to result, in economic damage, bodily injury or property damage. In addition, if any of our designed products are alleged to be defective, we may be required to participate in their recall. Depending on the significance of any particular customer and other relevant factors, we may agree to provide more favorable rights to such customer for valid defective product claims.

We maintain directors’ and officers’ insurance policies that indemnify our directors and officers against various liabilities, including certain liabilities under the Exchange Act that might be incurred by any director or officer in his or her capacity as such.

While our future obligations under certain agreements may contain limitations on liability for indemnification, other agreements do not contain such limitations, and under such agreements, it is not possible to predict the maximum potential amount of future payments due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, payments made by us under any of these indemnities have not had a material effect on our business, financial condition, results of operations or cash flows, and we do not believe that any amounts that we may be required to pay under these indemnities in the future will be material to our business, financial condition, results of operations or cash flows.

See Note 10: ''Commitments and Contingencies'' in the notes to our unaudited consolidated financial statements under the heading "Legal Matters" included elsewhere in this Form 10-Q for possible contingencies related to legal matters. See also Part I, Item 1 "Business - Government Regulation" of the 2021 Form 10-K for information on certain environmental matters.

~~Sources and Uses of Cash~~

Our balance of cash and cash equivalents was $1,645.1 million as of April 1, 2022. We require cash to: (i) fund our operating expenses, working capital requirements, outlays for strategic acquisitions and investments; (ii) service our debt, including principal and interest; (iii) conduct research and development; (iv) incur capital expenditures; and (v) repurchase our common stock.Overview

Our principal sources of liquidity are cash on hand, cash generated from operations, funds from external borrowings and equity issuances. In the near term, we expect to fund our primary cash requirements through cash generated from operations and with cash and cash equivalents on hand. We also have the ability to utilize our Revolving Credit Facility, which has approximately ~~$1.97~~$1.5 billion available for future borrowings. Our balance of cash and cash equivalents was $2,450.2 million as of September 30, 2022.

We require cash to: (i) fund our operating expenses, working capital requirements, outlays for strategic acquisitions and investments; (ii) service our debt, including principal and interest; (iii) conduct research and development; (iv) incur capital expenditures; and (v) repurchase our common stock.

During the ordinary course of business, we evaluate our cash requirements and, if necessary, adjust our expenditures to reflect the current market conditions and our projected sales and demand. Our capital expenditures are primarily directed towards manufacturing equipment, and can materially influence our available cash for other initiatives. Future capital expenditures may be impacted by events and transactions that are not currently forecasted.

We believe that our cash on hand, cash generated from our operations and the Revolving Credit Facility are adequate to meet our working capital requirements and other business needs for at least the next 12 months.

Operating Activities

Our long-term cash generation is dependent on the ability of our operations to generate cash. Our cash flows from operating activities were $1,901.8 million and $1,155.4 million for the nine months ended September 30, 2022 and October 1, 2021, respectively. The increase of $746.4 million was primarily attributable to a significant increase in net income due to our strategy to focus on a product mix that yields higher margins combined with increased demand and prices for our products.

Investing Activities

Our cash flows used in investing activities were $563.6 million and $327.5 million for the nine months ended September 30, 2022 and October 1, 2021, respectively. The increase of $236.1 million was primarily attributable to capital expenditures offset by proceeds from the sale of real estate and divestitures. During the nine months ended September 30, 2022 and October 1, 2021, we paid $663.0 million and $275.0 million, respectively, for capital expenditures.

Financing Activities

Our cash flows used in financing activities were $240.3 million and $517.8 million for the nine months ended September 30, 2022 and October 1, 2021, respectively. The decrease of $277.5 million was primarily attributable to proceeds and payments related to long-term borrowings and share repurchase activity.

We believe that the key factors that could affect our ~~internal and external~~ sources of cash include:

•changes in demand for our products, ~~including as a result of the COVID-19 pandemic,~~ competitive pricing pressures, supply chain constraints, effective management of our manufacturing capacity, ~~our ability to achieve further reductions in operating expenses,~~ our ability to make progress on the achievement of our business strategy and sustainability goals, the impact of our restructuring programs on our production and cost efficiency, inflationary pressures, and our ability to make the research and development expenditures required to remain competitive in our business; and

•our access to bank financing and the debt and equity capital markets that could ~~impair~~impact our ability to obtain needed financing on acceptable terms or to respond to business opportunities and developments as they arise, including interest rate fluctuations, macroeconomic conditions, sudden reductions in the general availability of lending from banks or the related increase in cost to obtain bank financing and our ability to maintain compliance with covenants under our debt agreements in effect from time to time.

~~Our ability to service our long-term debt, including our 0% Notes, 3.875% Notes, 1.625% Notes, the Revolving Credit Facility~~

Debt Guarantees and the Term Loan "B" Facility, to remain in compliance with the various covenants contained in our debt agreements and to fund working capital, capital expenditures and business development efforts will depend on our ability to generate cash from operating activities, which is subject to, among other things, our future operating performance and the timing of the full economic recovery from the COVID-19 pandemic, as well as financial, competitive, legislative, geopolitical, regulatory and other conditions, some of which may be beyond our control.Related Covenants

2938

Table of Contents

If we fail to generate sufficient cash from operations, we may need to raise additional equity or borrow additional funds to achieve our longer-term objectives. There can be no assurance that such equity or borrowings will be available or, if available, will be at rates or prices acceptable to us.

During the ordinary course of business, we evaluate our cash requirements and, if necessary, adjust our expenditures for inventory, operating expenditures and capital expenditures to reflect the current market conditions and our projected sales and demand. Our capital expenditures are primarily directed towards manufacturing equipment, and can materially influence our available cash for other initiatives. During the quarters ended April 1, 2022 and April 2, 2021, we paid $173.8 million and $77.0 million, respectively, for capital expenditures. We expect our capital expenditures to be in the range of 12% to 14% of revenue in 2022 to expand our manufacturing capabilities to meet the market demands and further improve our manufacturing cost structure. Future capital expenditures may be impacted by events and transactions that are not currently forecasted.

~~Primary Cash Flow Sources~~

Our long-term cash generation is dependent on the ability of our operations to generate cash. Our cash flows from operating activities were $478.6 million and $218.5 million for the quarters ended April 1, 2022 and April 2, 2021, respectively. The increase of $260.1 million was primarily attributable to a significant increase in net income due to our strategy to focus on a product mix that yields higher margins combined with better economic conditions resulting in increased demand for our products. Our ability to maintain positive operating cash flows is dependent on, among other factors, our success in achieving our revenue goals and manufacturing and operating cost targets. Management of our assets and liabilities, including both working capital and long-term assets and liabilities, also influences our operating cash flows, and each of these components is discussed below.

~~Working Capital~~

Working capital, calculated as total current assets less total current liabilities, fluctuates depending on end-market demand and our effective management of certain items such as receivables, inventory and payables. Our working capital, excluding cash and cash equivalents and the current portion of long-term debt, was $1,326.6 million as of April 1, 2022, and has fluctuated between $1,326.6 million and $885.0 million at the end of each of our last eight fiscal quarters. Our working capital, including cash and cash equivalents and the current portion of long-term debt, was $2,801.3 million as of April 1, 2022, and has fluctuated between $2,801.3 million and $1,457.6 million at the end of each of our last eight fiscal quarters. We expect an increase in capital expenditures during 2022.

~~Long-Term Assets and Liabilities~~

Our long-term assets consist primarily of property, plant and equipment, intangible assets, deferred taxes and goodwill. Our manufacturing rationalization plans have included efforts to utilize our existing manufacturing assets and supply arrangements more efficiently. We have taken actions to add manufacturing capacity with the acquisition of GTAT during 2021 and with the expected completion of the acquisition of the East Fishkill, New York fabrication facilities and certain related assets and liabilities on or around December 31, 2022. In connection with divestiture activities, we have wafer supply agreements in place for a period of time such that there is no disruption in our current ability to meet the demand for our products.

Our long-term liabilities, excluding long-term debt and deferred taxes, consist of liabilities under our foreign defined benefit pension plans, operating lease liabilities and contingent tax reserves. With regard to our foreign defined benefit pension plans, our annual funding of these obligations is equal to the minimum amount legally required in each jurisdiction in which the plans operate. This annual amount is dependent upon numerous actuarial assumptions. For additional information, See Note 6: ''Balance Sheet Information and Other'' and Note 13: ''Income Taxes'' in the notes to our unaudited consolidated financial statements included elsewhere in this Form 10-Q.

~~Key Financing and Capital Events~~

~~Overview~~

Over the past several years, we have undertaken various measures to secure liquidity to pursue acquisitions, repurchase shares of our common stock, reduce interest costs, amend existing key financing arrangements and, in some cases, extend a portion of our debt maturities to continue to provide us additional operating flexibility.

~~Table of Contents~~

~~Cash Management~~

Our ability to manage cash is limited, as our primary cash inflows and outflows are dictated by the terms of our sales and supply agreements, contractual obligations, debt instruments and legal and regulatory requirements. While we have some flexibility with respect to the timing of capital equipment purchases, we must invest in capital equipment on a timely basis to allow us to maintain our manufacturing efficiency and support our platforms for new products.

~~Debt Guarantees and Related Covenants~~

As of ~~April 1,~~September 30, 2022, we were in compliance with the indentures relating to our 0% Notes, 3.875% Notes and 1.625% Notes and with covenants relating to our Term Loan "B" Facility and Revolving Credit Facility. The 0% Notes, 3.875% Notes and 1.625% Notes are senior to the existing and future subordinated indebtedness of onsemi and its guarantor subsidiaries, rank equally in right of payment to all of our existing and future senior debt and, as unsecured obligations, are subordinated to all of our existing and future secured debt to the extent of the assets securing such debt.

Recent Accounting Pronouncements

For a discussion of recent accounting pronouncements, see our 2021 Form 10-K and Note 3: "Recent Accounting Pronouncements" in the notes to our unaudited consolidated financial statements included elsewhere in this Form 10-Q.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes in market risk from the information presented in Part II, Item 7A “Quantitative and Qualitative Disclosures About Market Risk,” in the 2021 Form 10-K.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered in this report, our disclosure controls and procedures were effective to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the required time periods and is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

We also carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during the fiscal quarter ended ~~April 1,~~September 30, 2022.

There have been no changes to our internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the fiscal quarter ended ~~April 1,~~September 30, 2022 which have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

3139

Table of Contents

PART II: OTHER INFORMATION

Item 1. Legal Proceedings

See Note ~~10: "Commitments~~11: ''Commitments and ~~Contingencies"~~Contingencies'' under the heading "Legal Matters" in the notes to the consolidated unaudited financial statements included elsewhere in this Form 10-Q for additional information on our legal proceedings and related matters. See also Part I, Item 1 "Business - Government Regulation" of the 2021 Form 10-K for information on certain environmental matters.

Item 1A. Risk Factors

Our business, financial condition and results of operations are subject to a number of trends, risks and uncertainties. We review and, where applicable, update our risk factors each quarter. There have been no material changes from the risk factors disclosed in Part I, Item 1A of the 2021 Form ~~10-K.~~10-K, except for the below.

Downturns or volatility in general economic conditions, as well as general macroeconomic trends and impacts, could have an adverse impact on our business, results of operations, financial condition and cash flows.

Historically, worldwide semiconductor industry sales have tracked the impacts of financial crises, subsequent recoveries and persistent economic uncertainty. We believe our business today is driven more by secular growth drivers and not solely by macroeconomic and industry cyclicality, as was the case historically, yet we could experience period-to-period fluctuations in operating results due to general industry or economic conditions, including the onset of an economic recession, and volatile or uncertain economic conditions can adversely impact our sales and profitability and make it difficult for us and our competitors to accurately forecast and plan our future business activities. Furthermore, inflationary pressure and increases in interest rates may negatively impact revenue, earnings and demand for our products.

In addition to general economic conditions, impacts of other macroeconomic events, such as the COVID-19 pandemic, climate change and other natural disasters, could materially adversely impact our operations by causing disruptions in the geographies in which we and our suppliers, third party distributors and sub-contractors operate. If any of these events impact our supply chain, manufacturing and product shipments could be delayed, which could materially adversely affect our business, results of operations and financial condition. In addition, disruption of transportation and distribution systems could result in reduced operational efficiency and customer service interruption. Such events can negatively impact revenue and earnings and can significantly impact cash flow.

Forward-Looking Statements

This Quarterly Report on Form 10-Q includes "forward-looking statements," as that term is defined in Section 27A of the Securities Act and Section 21E of the Exchange Act. All statements, other than statements of historical facts, included or incorporated in this Form 10-Q could be deemed forward-looking statements, particularly statements about our plans, strategies and prospects under the heading "Management’s Discussion and Analysis of Financial Condition and Results of Operations." Forward-looking statements are often characterized by the use of words such as "believes," "estimates," "expects," "projects," "may," "will," "intends," "plans" or "anticipates," or by discussions of strategy, plans or intentions. All forward-looking statements in this Form 10-Q are made based on our current expectations, forecasts, estimates and assumptions and involve risks, uncertainties and other factors that could cause results or events to differ materially from those expressed in the forward-looking statements. Certain factors that could affect our future results or events are described under Part I, Item 1A "Risk Factors" in the 2021 Form 10-K, in this Form 10-Q and from time to time in our other SEC reports. Readers are cautioned not to place undue reliance on forward-looking statements. We assume no obligation to update such information, except as may be required by law. You should carefully consider the trends, risks and uncertainties described in those reports and subsequent reports filed with or furnished to the SEC before making any investment decision with respect to our securities. If any of the following trends, risks or uncertainties actually occurs or continues, our business, financial condition or operating results could be materially adversely affected, the trading prices of our securities could decline and you could lose all or part of your investment. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by this cautionary statement.

3240

Table of Contents

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides information regarding repurchases of our common stock during the quarter ended ~~April 1,~~September 30, 2022:

~~Period~~ ~~(1)~~

~~Total Number of Shares Purchased~~

~~Average Price Paid per Share ($)~~

~~Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs~~

~~Approximate Dollar value of Shares that May Yet be Purchased Under the Plans or Programs (in millions) ($)~~

~~January 1, 2022 - January 28, 2022~~

—

~~1,295.8~~

~~January 29, 2022 - February 25, 2022~~

—

~~1,295.8~~

~~February 26, 2022 - April 1, 2022~~

—

~~1,295.8~~

~~Total~~

—


Period (1)	Total Number of Shares Purchased	Average Price Paid per Share ($)	Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar value of Shares that May Yet be Purchased Under the Plans or Programs (in millions) ($)
July 2, 2022 - July 29, 2022	138,000	59.75	138,000	1,197.9
July 30, 2022 - August 26, 2022	506,000	68.66	506,000	1,163.2
August 27, 2022 - September 30, 2022	552,000	67.27	552,000	1,126.1
Total	1,196,000	66.99	1,196,000

(1) These time periods represent our fiscal month start and end dates for the ~~first~~third quarter of 2022.

Shares withheld to satisfy statutory tax withholding requirements related to the vesting of share-based awards are not issued or considered repurchases of our common stock under our Share Repurchase Program and, therefore, are excluded from the table above.

Share Repurchase Program

Under the Share Repurchase Program, we may repurchase up to $1.5 billion (exclusive of fees, commissions and other expenses) of our common stock from December 1, 2018 through December 31, 2022, subject to certain contingencies. Subject to the discretion of our board of directors, we may repurchase our common stock from time to time in privately negotiated transactions or open market transactions, including pursuant to a trading plan in accordance with Rule 10b5-1 and Rule 10b-18 of the Exchange Act, and the timing of any repurchases and the actual number of shares repurchased depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under our debt obligations and other market and economic conditions. There were no1.2 million shares of the Company's common stock repurchased under the Share Repurchase Program during the quarter ended ~~April 1,~~September 30, 2022. As of September 30, 2022, the authorized amount remaining under the Share Repurchase Program was $1,126.1 million.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

3341

Table of Contents

Item 6. Exhibits

EXHIBIT INDEX

Exhibit No.

Exhibit Description*

~~10.1~~3.1

~~Form of Annual Restricted Stock Unit~~ ~~Award Agreement under the ON Semiconductor Corporation~~ Amended and Restated ~~Stock Incentive Plan (2022 form agreement)(1)(2).~~Bylaws (effective August 19, 2022)(incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the Commission on August 25, 2022)

~~10.2~~

~~Form of Annual Performance-Based Restricted Stock Unit~~ ~~Award Agreement under the ON Semiconductor Corporation Amended and Restated Stock Incentive Plan (2022 form agreement)(1)(2).~~

~~10.3~~

Amended and Restated Employment Agreement, effective June 1, 2017, by and between Semiconductor Components Industries, LLC and George H. Cave (incorporated by reference to Exhibit 10.12 to the Company’s Annual Report on Form 10-K filed with the Commission on February 21, 2018)(2).

~~10.4~~

Performance-Based Restricted Stock Units Award Agreement under the ON Semiconductor Corporation Amended and Restated Stock Incentive Plan (2021 form agreement for Tier I Employees) (incorporated by reference to Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q filed with the Commission on May 3, 2021)~~(2)~~

31.1

Certification by CEO pursuant to Rule 13(a)-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of Sarbanes-Oxley Act of 2002(1).

31.2

Certification by CFO pursuant to Rule 13(a)-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of Sarbanes-Oxley Act of 2002(1).

Certification by CEO and CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of ~~2002(~~3 )2002(2).

101.INS

XBRL Instance Document(1)

101.SCH

XBRL Taxonomy Extension Schema Document(1)

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document(1)

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document(1)

101.LAB

XBRL Taxonomy Extension Label Linkbase Document(1)

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document(1)

104

Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.


*			Reports filed under the Exchange Act (Form 10-K, Form 10-Q and Form 8-K) are filed under File No. 000-30419 and File No. 001-39317.
†			The Company has omitted certain schedules and exhibits pursuant to Item 601(b)(2) of Regulation S-K and, upon request by the Commission, agrees to furnish supplementally to the Commission a copy of any omitted schedule or exhibit.


(1)			Filed herewith.
(2)			~~Management contract or compensatory plan, contract or arrangement.~~Furnished herewith.
~~(3)~~			~~Furnished herewith.~~

3442

Table of Contents

SIGNATURES

Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.




		ON SEMICONDUCTOR CORPORATION (Registrant)

Date:	~~May 2,~~October 31, 2022	By:	/s/ THAD TRENT
			Thad Trent
			Executive Vice President, Chief Financial Officer and Treasurer
			(Principal Financial Officer and officer duly authorized to sign this report)

		By:	/s/ BERNARD R. COLPITTS, JR.
			Bernard R. Colpitts, Jr.
			Chief Accounting Officer
			(Principal Accounting Officer and officer duly authorized to sign this report)

3543